{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:35:02Z","timestamp":1794918902371,"version":"4.9.1"},"reference-count":367,"publisher":"Springer Science and Business Media LLC","issue":"17","license":[{"start":{"date-parts":[[2019,5,4]],"date-time":"2019-05-04T00:00:00Z","timestamp":1556928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,4]],"date-time":"2019-05-04T00:00:00Z","timestamp":1556928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007434","name":"Suzuken Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17k15729"],"award-info":[{"award-number":["17k15729"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00018-019-03125-1","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T09:24:22Z","timestamp":1557134662000},"page":"3323-3348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":531,"title":["Biological functions of mesenchymal stem cells and clinical implications"],"prefix":"10.1007","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1168-974X","authenticated-orcid":false,"given":"Abderrahim","family":"Naji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamitsu","family":"Eitoku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Favier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Deschaseaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Rouas-Freiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narufumi","family":"Suganuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,4]]},"reference":[{"key":"3125_CR1","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3727\/096368915X689622","volume":"25","author":"T Squillaro","year":"2016","unstructured":"Squillaro T, Peluso G, Galderisi U (2016) Clinical trials with mesenchymal stem cells: an update. Cell Transplant 25:829\u2013848. https:\/\/doi.org\/10.3727\/096368915X689622","journal-title":"Cell Transplant"},{"key":"3125_CR2","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","volume":"22","author":"J Galipeau","year":"2018","unstructured":"Galipeau J, Sensebe L (2018) Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell 22:824\u2013833. https:\/\/doi.org\/10.1016\/j.stem.2018.05.004","journal-title":"Cell Stem Cell"},{"key":"3125_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","volume":"17","author":"A Trounson","year":"2015","unstructured":"Trounson A, McDonald C (2015) Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell 17:11\u201322. https:\/\/doi.org\/10.1016\/j.stem.2015.06.007","journal-title":"Cell Stem Cell"},{"key":"3125_CR4","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1002\/stem.1494","volume":"31","author":"A Naji","year":"2013","unstructured":"Naji A et al (2013) Concise review: combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy. Stem Cells 31:2296\u20132303. https:\/\/doi.org\/10.1002\/stem.1494","journal-title":"Stem Cells"},{"key":"3125_CR5","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/aps.2013.50","volume":"34","author":"X Wei","year":"2013","unstructured":"Wei X et al (2013) Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin 34:747\u2013754. https:\/\/doi.org\/10.1038\/aps.2013.50","journal-title":"Acta Pharmacol Sin"},{"key":"3125_CR6","doi-asserted-by":"publisher","first-page":"713","DOI":"10.5966\/sctm.2016-0289","volume":"6","author":"A Naji","year":"2017","unstructured":"Naji A et al (2017) Rationale for determining the functional potency of mesenchymal stem cells in preventing regulated cell death for therapeutic use. Stem Cells Transl Med 6:713\u2013719. https:\/\/doi.org\/10.5966\/sctm.2016-0289","journal-title":"Stem Cells Transl Med"},{"key":"3125_CR7","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1002\/stem.2415","volume":"34","author":"R Chinnadurai","year":"2016","unstructured":"Chinnadurai R et al (2016) Cryopreserved mesenchymal stromal cells are susceptible to T-cell mediated apoptosis which is partly rescued by IFNgamma licensing. Stem Cells 34:2429\u20132442. https:\/\/doi.org\/10.1002\/stem.2415","journal-title":"Stem Cells"},{"key":"3125_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jcyt.2012.10.002","volume":"15","author":"J Galipeau","year":"2013","unstructured":"Galipeau J (2013) The mesenchymal stromal cells dilemma: does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? Cytotherapy 15:2\u20138. https:\/\/doi.org\/10.1016\/j.jcyt.2012.10.002","journal-title":"Cytotherapy"},{"key":"3125_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jcyt.2014.12.008","volume":"17","author":"J Galipeau","year":"2015","unstructured":"Galipeau J, Krampera M (2015) The challenge of defining mesenchymal stromal cell potency assays and their potential use as release criteria. Cytotherapy 17:125\u2013127. https:\/\/doi.org\/10.1016\/j.jcyt.2014.12.008","journal-title":"Cytotherapy"},{"key":"3125_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jcyt.2015.11.008","volume":"18","author":"J Galipeau","year":"2016","unstructured":"Galipeau J et al (2016) International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. Cytotherapy 18:151\u2013159. https:\/\/doi.org\/10.1016\/j.jcyt.2015.11.008","journal-title":"Cytotherapy"},{"key":"3125_CR11","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nm.3220","volume":"19","author":"DG Phinney","year":"2013","unstructured":"Phinney DG et al (2013) MSCs: science and trials. Nat Med 19:812. https:\/\/doi.org\/10.1038\/nm.3220","journal-title":"Nat Med"},{"key":"3125_CR12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nbt0318-212a","volume":"36","author":"C Sheridan","year":"2018","unstructured":"Sheridan C (2018) First off-the-shelf mesenchymal stem cell therapy nears European approval. Nat Biotechnol 36:212\u2013214. https:\/\/doi.org\/10.1038\/nbt0318-212a","journal-title":"Nat Biotechnol"},{"key":"3125_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.stem.2008.03.002","volume":"2","author":"P Bianco","year":"2008","unstructured":"Bianco P, Robey PG, Simmons PJ (2008) Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2:313\u2013319. https:\/\/doi.org\/10.1016\/j.stem.2008.03.002","journal-title":"Cell Stem Cell"},{"key":"3125_CR14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/cdd.2013.158","volume":"21","author":"S Ma","year":"2014","unstructured":"Ma S et al (2014) Immunobiology of mesenchymal stem cells. Cell Death Differ 21:216\u2013225. https:\/\/doi.org\/10.1038\/cdd.2013.158","journal-title":"Cell Death Differ"},{"key":"3125_CR15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nrm3049","volume":"12","author":"C Nombela-Arrieta","year":"2011","unstructured":"Nombela-Arrieta C, Ritz J, Silberstein LE (2011) The elusive nature and function of mesenchymal stem cells. Nat Rev Mol Cell Biol 12:126\u2013131. https:\/\/doi.org\/10.1038\/nrm3049","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3125_CR16","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.stemcr.2016.05.011","volume":"6","author":"B Sacchetti","year":"2016","unstructured":"Sacchetti B et al (2016) No identical \u201cmesenchymal stem cells\u201d at different times and sites: human committed progenitors of distinct origin and differentiation potential are incorporated as adventitial cells in microvessels. Stem Cell Rep 6:897\u2013913. https:\/\/doi.org\/10.1016\/j.stemcr.2016.05.011","journal-title":"Stem Cell Rep"},{"key":"3125_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13287-016-0363-7","volume":"7","author":"JL Spees","year":"2016","unstructured":"Spees JL, Lee RH, Gregory CA (2016) Mechanisms of mesenchymal stem\/stromal cell function. Stem Cell Res Ther 7:125. https:\/\/doi.org\/10.1186\/s13287-016-0363-7","journal-title":"Stem Cell Res Ther"},{"key":"3125_CR18","first-page":"393","volume":"3","author":"AJ Friedenstein","year":"1970","unstructured":"Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393\u2013403","journal-title":"Cell Tissue Kinet"},{"key":"3125_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/00007890-197404000-00001","volume":"17","author":"AJ Friedenstein","year":"1974","unstructured":"Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV (1974) Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17:331\u2013340","journal-title":"Transplantation"},{"key":"3125_CR20","first-page":"83","volume":"2","author":"AJ Friedenstein","year":"1974","unstructured":"Friedenstein AJ et al (1974) Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2:83\u201392","journal-title":"Exp Hematol"},{"key":"3125_CR21","first-page":"267","volume":"4","author":"AJ Friedenstein","year":"1976","unstructured":"Friedenstein AJ, Gorskaja JF, Kulagina NN (1976) Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4:267\u2013274","journal-title":"Exp Hematol"},{"key":"3125_CR22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/00007890-196803000-00009","volume":"6","author":"AJ Friedenstein","year":"1968","unstructured":"Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP (1968) Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6:230\u2013247","journal-title":"Transplantation"},{"key":"3125_CR23","first-page":"381","volume":"16","author":"AJ Friedenstein","year":"1966","unstructured":"Friedenstein AJ, Piatetzky S II, Petrakova KV (1966) Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 16:381\u2013390","journal-title":"J Embryol Exp Morphol"},{"key":"3125_CR24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood.V56.2.289.289","volume":"56","author":"H Castro-Malaspina","year":"1980","unstructured":"Castro-Malaspina H et al (1980) Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 56:289\u2013301","journal-title":"Blood"},{"key":"3125_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/stem.5530020602","volume":"2","author":"I Jinnai","year":"1984","unstructured":"Jinnai I, Bessho M, Murohashi I, Nara N, Hirashima K (1984) Relationship between fibroblastoid colony-forming units (CFU-f) and hemopoietic precursor cells in normal human bone marrow. Int J Cell Cloning 2:341\u2013347. https:\/\/doi.org\/10.1002\/stem.5530020602","journal-title":"Int J Cell Cloning"},{"key":"3125_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000206383","volume":"72","author":"N Nara","year":"1984","unstructured":"Nara N, Jinnai I, Imai Y, Bessho M, Hirashima K (1984) Reduction of granulocyte-macrophage progenitor cells (CFU-C) and fibroblastoid colony-forming units (CFU-F) by leukemic cells in human and murine leukemia. Acta Haematol 72:171\u2013180. https:\/\/doi.org\/10.1159\/000206383","journal-title":"Acta Haematol"},{"key":"3125_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1177\/096368979200100106","volume":"1","author":"JE Dennis","year":"1992","unstructured":"Dennis JE, Haynesworth SE, Young RG, Caplan AI (1992) Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: effect of fibronectin and laminin on cell retention and rate of osteogenic expression. Cell Transplant 1:23\u201332","journal-title":"Cell Transplant"},{"key":"3125_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1242\/jcs.1988.Supplement_10.5","volume":"10","author":"M Owen","year":"1988","unstructured":"Owen M (1988) Marrow stromal stem cells. J Cell Sci Suppl 10:63\u201376","journal-title":"J Cell Sci Suppl"},{"key":"3125_CR29","first-page":"42","volume":"136","author":"M Owen","year":"1988","unstructured":"Owen M, Friedenstein AJ (1988) Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp 136:42\u201360","journal-title":"Ciba Found Symp"},{"key":"3125_CR30","first-page":"17","volume":"1","author":"J Chang","year":"1989","unstructured":"Chang J, Allen TD, Dexter TM (1989) Long-term bone marrow cultures: their use in autologous marrow transplantation. Cancer Cells 1:17\u201324","journal-title":"Cancer Cells"},{"key":"3125_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/jcp.1041130414","volume":"1","author":"TM Dexter","year":"1982","unstructured":"Dexter TM (1982) Stromal cell associated haemopoiesis. J Cell Physiol Suppl 1:87\u201394","journal-title":"J Cell Physiol Suppl"},{"key":"3125_CR32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1146\/annurev.cb.03.110187.002231","volume":"3","author":"TM Dexter","year":"1987","unstructured":"Dexter TM, Spooncer E (1987) Growth and differentiation in the hemopoietic system. Annu Rev Cell Biol 3:423\u2013441. https:\/\/doi.org\/10.1146\/annurev.cb.03.110187.002231","journal-title":"Annu Rev Cell Biol"},{"key":"3125_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1242\/jcs.1985.Supplement_3.9","volume":"3","author":"TM Dexter","year":"1985","unstructured":"Dexter TM, Whetton AD, Spooncer E, Heyworth C, Simmons P (1985) The role of stromal cells and growth factors in haemopoiesis and modulation of their effects by the src oncogene. J Cell Sci Suppl 3:83\u201395","journal-title":"J Cell Sci Suppl"},{"key":"3125_CR34","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00003086-198903000-00035","volume":"240","author":"JN Beresford","year":"1989","unstructured":"Beresford JN (1989) Osteogenic stem cells and the stromal system of bone and marrow. Clin Orthop Relat Res 240:270\u2013280","journal-title":"Clin Orthop Relat Res"},{"key":"3125_CR35","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/blood.V59.5.1046.1046","volume":"59","author":"H Castro-Malaspina","year":"1982","unstructured":"Castro-Malaspina H et al (1982) Characteristics of bone marrow fibroblast colony-forming cells (CFU-F) and their progeny in patients with myeloproliferative disorders. Blood 59:1046\u20131054","journal-title":"Blood"},{"key":"3125_CR36","first-page":"209","volume":"154","author":"H Castro-Malaspina","year":"1984","unstructured":"Castro-Malaspina H, Ebell W, Wang S (1984) Human bone marrow fibroblast colony-forming units (CFU-F). Prog Clin Biol Res 154:209\u2013236","journal-title":"Prog Clin Biol Res"},{"key":"3125_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/8756-3282(92)90363-2","volume":"13","author":"SE Haynesworth","year":"1992","unstructured":"Haynesworth SE, Baber MA, Caplan AI (1992) Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13:69\u201380","journal-title":"Bone"},{"key":"3125_CR38","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6","volume":"166","author":"SE Haynesworth","year":"1996","unstructured":"Haynesworth SE, Baber MA, Caplan AI (1996) Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J Cell Physiol 166:585\u2013592. https:\/\/doi.org\/10.1002\/(SICI)1097-4652(199603)166:3%3c585:AID-JCP13%3e3.0.CO;2-6","journal-title":"J Cell Physiol"},{"key":"3125_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/8756-3282(92)90364-3","volume":"13","author":"SE Haynesworth","year":"1992","unstructured":"Haynesworth SE, Goshima J, Goldberg VM, Caplan AI (1992) Characterization of cells with osteogenic potential from human marrow. Bone 13:81\u201388","journal-title":"Bone"},{"key":"3125_CR40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I","volume":"64","author":"N Jaiswal","year":"1997","unstructured":"Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP (1997) Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64:295\u2013312","journal-title":"J Cell Biochem"},{"key":"3125_CR41","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/BF02631426","volume":"29A","author":"J Vilamitjana-Amedee","year":"1993","unstructured":"Vilamitjana-Amedee J, Bareille R, Rouais F, Caplan AI, Harmand MF (1993) Human bone marrow stromal cells express an osteoblastic phenotype in culture. Vitro Cell Dev Biol Anim 29A:699\u2013707","journal-title":"Vitro Cell Dev Biol Anim"},{"key":"3125_CR42","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/jor.1100090504","volume":"9","author":"AI Caplan","year":"1991","unstructured":"Caplan AI (1991) Mesenchymal stem cells. J Orthop Res 9:641\u2013650. https:\/\/doi.org\/10.1002\/jor.1100090504","journal-title":"J Orthop Res"},{"key":"3125_CR43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jcb.240560303","volume":"56","author":"SP Bruder","year":"1994","unstructured":"Bruder SP, Fink DJ, Caplan AI (1994) Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 56:283\u2013294. https:\/\/doi.org\/10.1002\/jcb.240560303","journal-title":"J Cell Biochem"},{"key":"3125_CR44","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev-cellbio-100913-013132","volume":"30","author":"P Bianco","year":"2014","unstructured":"Bianco P (2014) \u201cMesenchymal\u201d stem cells. Annu Rev Cell Dev Biol 30:677\u2013704. https:\/\/doi.org\/10.1146\/annurev-cellbio-100913-013132","journal-title":"Annu Rev Cell Dev Biol"},{"key":"3125_CR45","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/sctm.17-0051","volume":"6","author":"AI Caplan","year":"2017","unstructured":"Caplan AI (2017) Mesenchymal stem cells: time to change the name! Stem Cells Transl Med 6:1445\u20131451. https:\/\/doi.org\/10.1002\/sctm.17-0051","journal-title":"Stem Cells Transl Med"},{"key":"3125_CR46","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13287-018-0833-1","volume":"9","author":"D Bhartiya","year":"2018","unstructured":"Bhartiya D (2018) The need to revisit the definition of mesenchymal and adult stem cells based on their functional attributes. Stem Cell Res Ther 9:78. https:\/\/doi.org\/10.1186\/s13287-018-0833-1","journal-title":"Stem Cell Res Ther"},{"key":"3125_CR47","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/jcb.20886","volume":"98","author":"AI Caplan","year":"2006","unstructured":"Caplan AI, Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98:1076\u20131084. https:\/\/doi.org\/10.1002\/jcb.20886","journal-title":"J Cell Biochem"},{"key":"3125_CR48","first-page":"557","volume":"16","author":"HM Lazarus","year":"1995","unstructured":"Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI (1995) Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 16:557\u2013564","journal-title":"Bone Marrow Transplant"},{"key":"3125_CR49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/14653240500319234","volume":"7","author":"EM Horwitz","year":"2005","unstructured":"Horwitz EM et al (2005) Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy 7:393\u2013395. https:\/\/doi.org\/10.1080\/14653240500319234","journal-title":"Cytotherapy"},{"key":"3125_CR50","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1089\/hum.2010.115","volume":"21","author":"P Charbord","year":"2010","unstructured":"Charbord P (2010) Bone marrow mesenchymal stem cells: historical overview and concepts. Hum Gene Ther 21:1045\u20131056. https:\/\/doi.org\/10.1089\/hum.2010.115","journal-title":"Hum Gene Ther"},{"key":"3125_CR51","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2217\/17460751.1.4.497","volume":"1","author":"B Delorme","year":"2006","unstructured":"Delorme B, Chateauvieux S, Charbord P (2006) The concept of mesenchymal stem cells. Regen Med 1:497\u2013509. https:\/\/doi.org\/10.2217\/17460751.1.4.497","journal-title":"Regen Med"},{"key":"3125_CR52","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jcyt.2012.11.005","volume":"15","author":"DG Phinney","year":"2013","unstructured":"Phinney DG, Sensebe L (2013) Mesenchymal stromal cells: misconceptions and evolving concepts. Cytotherapy 15:140\u2013145. https:\/\/doi.org\/10.1016\/j.jcyt.2012.11.005","journal-title":"Cytotherapy"},{"key":"3125_CR53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.carrev.2005.10.008","volume":"7","author":"S Bhakta","year":"2006","unstructured":"Bhakta S, Hong P, Koc O (2006) The surface adhesion molecule CXCR53 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation. Cardiovasc Revasc Med 7:19\u201324. https:\/\/doi.org\/10.1016\/j.carrev.2005.10.008","journal-title":"Cardiovasc Revasc Med"},{"key":"3125_CR54","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1634\/stemcells.2007-0197","volume":"25","author":"G Chamberlain","year":"2007","unstructured":"Chamberlain G, Fox J, Ashton B, Middleton J (2007) Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25:2739\u20132749. https:\/\/doi.org\/10.1634\/stemcells.2007-0197","journal-title":"Stem Cells"},{"key":"3125_CR55","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/sj.mt.6300374","volume":"16","author":"Z Cheng","year":"2008","unstructured":"Cheng Z et al (2008) Targeted migration of mesenchymal stem cells modified with CXCR55 gene to infarcted myocardium improves cardiac performance. Mol Ther 16:571\u2013579. https:\/\/doi.org\/10.1038\/sj.mt.6300374","journal-title":"Mol Ther"},{"key":"3125_CR56","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3324\/haematol.10475","volume":"92","author":"A De Becker","year":"2007","unstructured":"De Becker A et al (2007) Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica 92:440\u2013449","journal-title":"Haematologica"},{"key":"3125_CR57","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1159\/000143110","volume":"35","author":"R Henschler","year":"2008","unstructured":"Henschler R, Deak E, Seifried E (2008) Homing of mesenchymal stem cells. Transfus Med Hemother 35:306\u2013312. https:\/\/doi.org\/10.1159\/000143110","journal-title":"Transfus Med Hemother"},{"key":"3125_CR58","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1634\/stemcells.22-3-415","volume":"22","author":"JF Ji","year":"2004","unstructured":"Ji JF, He BP, Dheen ST, Tay SS (2004) Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 22:415\u2013427. https:\/\/doi.org\/10.1634\/stemcells.22-3-415","journal-title":"Stem Cells"},{"key":"3125_CR59","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nm1703","volume":"14","author":"R Sackstein","year":"2008","unstructured":"Sackstein R et al (2008) Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med 14:181\u2013187. https:\/\/doi.org\/10.1038\/nm1703","journal-title":"Nat Med"},{"key":"3125_CR60","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1634\/stemcells.2005-0271","volume":"24","author":"BR Son","year":"2006","unstructured":"Son BR et al (2006) Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR60 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 24:1254\u20131264. https:\/\/doi.org\/10.1634\/stemcells.2005-0271","journal-title":"Stem Cells"},{"key":"3125_CR61","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1182\/blood-2004-09-3507","volume":"106","author":"V Sordi","year":"2005","unstructured":"Sordi V et al (2005) Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 106:419\u2013427. https:\/\/doi.org\/10.1182\/blood-2004-09-3507","journal-title":"Blood"},{"key":"3125_CR62","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/01.TP.0000048488.35010.95","volume":"75","author":"GD Wu","year":"2003","unstructured":"Wu GD et al (2003) Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation 75:679\u2013685. https:\/\/doi.org\/10.1097\/01.TP.0000048488.35010.95","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"3125_CR63","first-page":"S76","volume":"7","author":"SM Devine","year":"2001","unstructured":"Devine SM, Peter S, Martin BJ, Barry F, McIntosh KR (2001) Mesenchymal stem cells: stealth and suppression. Cancer J 7(Suppl 2):S76\u2013S82","journal-title":"Cancer J"},{"key":"3125_CR64","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1182\/blood-2003-04-1193","volume":"102","author":"F Djouad","year":"2003","unstructured":"Djouad F et al (2003) Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102:3837\u20133844. https:\/\/doi.org\/10.1182\/blood-2003-04-1193","journal-title":"Blood"},{"key":"3125_CR65","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","volume":"105","author":"S Aggarwal","year":"2005","unstructured":"Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815\u20131822. https:\/\/doi.org\/10.1182\/blood-2004-04-1559","journal-title":"Blood"},{"key":"3125_CR66","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/14653240310003611","volume":"5","author":"K Le Blanc","year":"2003","unstructured":"Le Blanc K (2003) Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 5:485\u2013489. https:\/\/doi.org\/10.1080\/14653240310003611","journal-title":"Cytotherapy"},{"key":"3125_CR67","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/sj.bmt.1704400","volume":"33","author":"B Maitra","year":"2004","unstructured":"Maitra B et al (2004) Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 33:597\u2013604. https:\/\/doi.org\/10.1038\/sj.bmt.1704400","journal-title":"Bone Marrow Transplant"},{"key":"3125_CR68","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/01.TP.0000045055.63901.A9","volume":"75","author":"WT Tse","year":"2003","unstructured":"Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75:389\u2013397. https:\/\/doi.org\/10.1097\/01.TP.0000045055.63901.A9","journal-title":"Transplantation"},{"key":"3125_CR69","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/path.2469","volume":"217","author":"AI Caplan","year":"2009","unstructured":"Caplan AI (2009) Why are MSCs therapeutic? New data: new insight. J Pathol 217:318\u2013324. https:\/\/doi.org\/10.1002\/path.2469","journal-title":"J Pathol"},{"key":"3125_CR70","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1478-811X-9-12","volume":"9","author":"R Hass","year":"2011","unstructured":"Hass R, Kasper C, Bohm S, Jacobs R (2011) Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 9:12. https:\/\/doi.org\/10.1186\/1478-811X-9-12","journal-title":"Cell Commun Signal"},{"key":"3125_CR71","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/ar2116","volume":"9","author":"CM Kolf","year":"2007","unstructured":"Kolf CM, Cho E, Tuan RS (2007) Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 9:204. https:\/\/doi.org\/10.1186\/ar2116","journal-title":"Arthritis Res Ther"},{"key":"3125_CR72","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12016-016-8552-9","volume":"52","author":"AT Maria","year":"2017","unstructured":"Maria AT et al (2017) Adipose-derived mesenchymal stem cells in autoimmune disorders: state of the art and perspectives for systemic sclerosis. Clin Rev Allergy Immunol 52:234\u2013259. https:\/\/doi.org\/10.1007\/s12016-016-8552-9","journal-title":"Clin Rev Allergy Immunol"},{"key":"3125_CR73","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143\u2013147","journal-title":"Science"},{"key":"3125_CR74","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/978-3-540-77855-4_11","volume":"174","author":"N Beyer Nardi","year":"2006","unstructured":"Beyer Nardi N, da Silva Meirelles L (2006) Mesenchymal stem cells: isolation, in vitro expansion and characterization. Handb Exp Pharmacol 174:249\u2013282. https:\/\/doi.org\/10.1007\/978-3-540-77855-4_11","journal-title":"Handb Exp Pharmacol"},{"key":"3125_CR75","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1242\/jcs.02932","volume":"119","author":"L da Silva Meirelles","year":"2006","unstructured":"da Silva Meirelles L, Chagastelles PC, Nardi NB (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119:2204\u20132213. https:\/\/doi.org\/10.1242\/jcs.02932","journal-title":"J Cell Sci"},{"key":"3125_CR76","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1242\/jcs.00369","volume":"116","author":"S Gronthos","year":"2003","unstructured":"Gronthos S et al (2003) Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116:1827\u20131835","journal-title":"J Cell Sci"},{"key":"3125_CR77","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1359\/jbmr.2003.18.4.696","volume":"18","author":"S Shi","year":"2003","unstructured":"Shi S, Gronthos S (2003) Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 18:696\u2013704. https:\/\/doi.org\/10.1359\/jbmr.2003.18.4.696","journal-title":"J Bone Miner Res"},{"key":"3125_CR78","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-1-60327-169-1_3","volume":"449","author":"S Gronthos","year":"2008","unstructured":"Gronthos S, Zannettino AC (2008) A method to isolate and purify human bone marrow stromal stem cells. Methods Mol Biol 449:45\u201357. https:\/\/doi.org\/10.1007\/978-1-60327-169-1_3","journal-title":"Methods Mol Biol"},{"key":"3125_CR79","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/jcp.21210","volume":"214","author":"AC Zannettino","year":"2008","unstructured":"Zannettino AC et al (2008) Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol 214:413\u2013421. https:\/\/doi.org\/10.1002\/jcp.21210","journal-title":"J Cell Physiol"},{"key":"3125_CR80","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","volume":"24","author":"S Kern","year":"2006","unstructured":"Kern S, Eichler H, Stoeve J, Kluter H, Bieback K (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294\u20131301. https:\/\/doi.org\/10.1634\/stemcells.2005-0342","journal-title":"Stem Cells"},{"key":"3125_CR81","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000080341","volume":"14","author":"RH Lee","year":"2004","unstructured":"Lee RH et al (2004) Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 14:311\u2013324. https:\/\/doi.org\/10.1159\/000080341","journal-title":"Cell Physiol Biochem"},{"key":"3125_CR82","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1091\/mbc.e02-02-0105","volume":"13","author":"PA Zuk","year":"2002","unstructured":"Zuk PA et al (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279\u20134295. https:\/\/doi.org\/10.1091\/mbc.e02-02-0105","journal-title":"Mol Biol Cell"},{"key":"3125_CR83","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41551-018-0325-8","volume":"3","author":"JQ Yin","year":"2019","unstructured":"Yin JQ, Zhu J, Ankrum JA (2019) Manufacturing of primed mesenchymal stromal cells for therapy. Nat Biomed Eng 3:90\u2013104. https:\/\/doi.org\/10.1038\/s41551-018-0325-8","journal-title":"Nat Biomed Eng"},{"key":"3125_CR84","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12929-016-0289-5","volume":"23","author":"LT Wang","year":"2016","unstructured":"Wang LT et al (2016) Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials. J Biomed Sci 23:76. https:\/\/doi.org\/10.1186\/s12929-016-0289-5","journal-title":"J Biomed Sci"},{"key":"3125_CR85","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1634\/stemcells.21-2-190","volume":"21","author":"HS Lee","year":"2003","unstructured":"Lee HS et al (2003) Multipotential mesenchymal stem cells from femoral bone marrow near the site of osteonecrosis. Stem Cells 21:190\u2013199. https:\/\/doi.org\/10.1634\/stemcells.21-2-190","journal-title":"Stem Cells"},{"key":"3125_CR86","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/978-1-62703-128-8_20","volume":"946","author":"R Wagey","year":"2013","unstructured":"Wagey R, Short B (2013) Isolation, enumeration, and expansion of human mesenchymal stem cells in culture. Methods Mol Biol 946:315\u2013334. https:\/\/doi.org\/10.1007\/978-1-62703-128-8_20","journal-title":"Methods Mol Biol"},{"key":"3125_CR87","first-page":"S3","volume":"18","author":"L Sensebe","year":"2008","unstructured":"Sensebe L (2008) Clinical grade production of mesenchymal stem cells. Biomed Mater Eng 18:S3\u2013S10","journal-title":"Biomed Mater Eng"},{"key":"3125_CR88","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13287-017-0483-8","volume":"8","author":"J Varghese","year":"2017","unstructured":"Varghese J, Griffin M, Mosahebi A, Butler P (2017) Systematic review of patient factors affecting adipose stem cell viability and function: implications for regenerative therapy. Stem Cell Res Ther 8:45. https:\/\/doi.org\/10.1186\/s13287-017-0483-8","journal-title":"Stem Cell Res Ther"},{"key":"3125_CR89","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/107632701300062859","volume":"7","author":"PA Zuk","year":"2001","unstructured":"Zuk PA et al (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211\u2013228. https:\/\/doi.org\/10.1089\/107632701300062859","journal-title":"Tissue Eng"},{"key":"3125_CR90","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4252\/wjsc.v6.i2.195","volume":"6","author":"T Nagamura-Inoue","year":"2014","unstructured":"Nagamura-Inoue T, He H (2014) Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility. World J Stem Cells 6:195\u2013202. https:\/\/doi.org\/10.4252\/wjsc.v6.i2.195","journal-title":"World J Stem Cells"},{"key":"3125_CR91","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4252\/wjsc.v2.i4.81","volume":"2","author":"K Bieback","year":"2010","unstructured":"Bieback K, Brinkmann I (2010) Mesenchymal stromal cells from human perinatal tissues: from biology to cell therapy. World J Stem Cells 2:81\u201392. https:\/\/doi.org\/10.4252\/wjsc.v2.i4.81","journal-title":"World J Stem Cells"},{"key":"3125_CR92","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.tem.2016.03.016","volume":"27","author":"EL Scheller","year":"2016","unstructured":"Scheller EL, Cawthorn WP, Burr AA, Horowitz MC, MacDougald OA (2016) Marrow adipose tissue: trimming the fat. Trends Endocrinol Metab 27:392\u2013403. https:\/\/doi.org\/10.1016\/j.tem.2016.03.016","journal-title":"Trends Endocrinol Metab"},{"key":"3125_CR93","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/ATVBAHA.109.191643","volume":"30","author":"M Corselli","year":"2010","unstructured":"Corselli M, Chen CW, Crisan M, Lazzari L, Peault B (2010) Perivascular ancestors of adult multipotent stem cells. Arterioscler Thromb Vasc Biol 30:1104\u20131109. https:\/\/doi.org\/10.1161\/ATVBAHA.109.191643","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3125_CR94","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/ten.TEA.2013.0197","volume":"20","author":"N Song","year":"2014","unstructured":"Song N, Armstrong AD, Li F, Ouyang H, Niyibizi C (2014) Multipotent mesenchymal stem cells from human subacromial bursa: potential for cell based tendon tissue engineering. Tissue Eng Part A 20:239\u2013249. https:\/\/doi.org\/10.1089\/ten.TEA.2013.0197","journal-title":"Tissue Eng Part A"},{"key":"3125_CR95","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/jid.2011.355","volume":"132","author":"C Vaculik","year":"2012","unstructured":"Vaculik C et al (2012) Human dermis harbors distinct mesenchymal stromal cell subsets. J Invest Dermatol 132:563\u2013574. https:\/\/doi.org\/10.1038\/jid.2011.355","journal-title":"J Invest Dermatol"},{"key":"3125_CR96","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1089\/ten.TEA.2009.0796","volume":"16","author":"BP Fournier","year":"2010","unstructured":"Fournier BP et al (2010) Multipotent progenitor cells in gingival connective tissue. Tissue Eng Part A 16:2891\u20132899. https:\/\/doi.org\/10.1089\/ten.TEA.2009.0796","journal-title":"Tissue Eng Part A"},{"key":"3125_CR97","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1365-2184.2009.00611.x","volume":"42","author":"MT Cheng","year":"2009","unstructured":"Cheng MT, Yang HW, Chen TH, Lee OK (2009) Isolation and characterization of multipotent stem cells from human cruciate ligaments. Cell Prolif 42:448\u2013460. https:\/\/doi.org\/10.1111\/j.1365-2184.2009.00611.x","journal-title":"Cell Prolif"},{"key":"3125_CR98","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/jor.21556","volume":"30","author":"PP Chong","year":"2012","unstructured":"Chong PP, Selvaratnam L, Abbas AA, Kamarul T (2012) Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells. J Orthop Res 30:634\u2013642. https:\/\/doi.org\/10.1002\/jor.21556","journal-title":"J Orthop Res"},{"key":"3125_CR99","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1089\/ten.teb.2008.0586","volume":"15","author":"J Fan","year":"2009","unstructured":"Fan J, Varshney RR, Ren L, Cai D, Wang DA (2009) Synovium-derived mesenchymal stem cells: a new cell source for musculoskeletal regeneration. Tissue Eng Part B Rev 15:75\u201386. https:\/\/doi.org\/10.1089\/ten.teb.2008.0586","journal-title":"Tissue Eng Part B Rev"},{"key":"3125_CR100","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.cellbi.2006.03.009","volume":"30","author":"Z Miao","year":"2006","unstructured":"Miao Z et al (2006) Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol Int 30:681\u2013687. https:\/\/doi.org\/10.1016\/j.cellbi.2006.03.009","journal-title":"Cell Biol Int"},{"key":"3125_CR101","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/stem.2795","volume":"36","author":"LT Wang","year":"2018","unstructured":"Wang LT et al (2018) Differentiation of mesenchymal stem cells from human induced pluripotent stem cells results in downregulation of c-Myc and DNA replication pathways with immunomodulation toward CD4 and CD8 cells. Stem Cells 36:903\u2013914. https:\/\/doi.org\/10.1002\/stem.2795","journal-title":"Stem Cells"},{"key":"3125_CR102","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/BF02724045","volume":"32","author":"DP Lennon","year":"1996","unstructured":"Lennon DP, Haynesworth SE, Bruder SP, Jaiswal N, Caplan AI (1996) Human and animal mesenchymal progenitor cells from bone marrow: identification of serum for optimal selection and proliferation. Vitro Cell Dev Biol Anim 32:602\u2013611","journal-title":"Vitro Cell Dev Biol Anim"},{"key":"3125_CR103","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.3727\/096368912X657990","volume":"22","author":"MT Rojewski","year":"2013","unstructured":"Rojewski MT et al (2013) GMP-compliant isolation and expansion of bone marrow-derived MSCs in the closed, automated device quantum cell expansion system. Cell Transplant 22:1981\u20132000. https:\/\/doi.org\/10.3727\/096368912X657990","journal-title":"Cell Transplant"},{"key":"3125_CR104","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/scrt232","volume":"4","author":"MC Corotchi","year":"2013","unstructured":"Corotchi MC et al (2013) Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton\u2019s jelly-derived mesenchymal stem cells. Stem Cell Res Ther 4:81. https:\/\/doi.org\/10.1186\/scrt232","journal-title":"Stem Cell Res Ther"},{"key":"3125_CR105","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1002\/bit.25187","volume":"111","author":"F Dos Santos","year":"2014","unstructured":"Dos Santos F et al (2014) A xenogeneic-free bioreactor system for the clinical-scale expansion of human mesenchymal stem\/stromal cells. Biotechnol Bioeng 111:1116\u20131127. https:\/\/doi.org\/10.1002\/bit.25187","journal-title":"Biotechnol Bioeng"},{"key":"3125_CR106","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/scrt217","volume":"4","author":"L Sensebe","year":"2013","unstructured":"Sensebe L, Gadelorge M, Fleury-Cappellesso S (2013) Production of mesenchymal stromal\/stem cells according to good manufacturing practices: a review. Stem Cell Res Ther 4:66. https:\/\/doi.org\/10.1186\/scrt217","journal-title":"Stem Cell Res Ther"},{"key":"3125_CR107","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/jcp.21987","volume":"223","author":"F Dos Santos","year":"2010","unstructured":"Dos Santos F et al (2010) Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia. J Cell Physiol 223:27\u201335. https:\/\/doi.org\/10.1002\/jcp.21987","journal-title":"J Cell Physiol"},{"key":"3125_CR108","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s10616-014-9731-2","volume":"67","author":"C Fotia","year":"2015","unstructured":"Fotia C, Massa A, Boriani F, Baldini N, Granchi D (2015) Hypoxia enhances proliferation and stemness of human adipose-derived mesenchymal stem cells. Cytotechnology 67:1073\u20131084. https:\/\/doi.org\/10.1007\/s10616-014-9731-2","journal-title":"Cytotechnology"},{"key":"3125_CR109","doi-asserted-by":"publisher","first-page":"871","DOI":"10.5966\/sctm.2013-0050","volume":"2","author":"S Eaker","year":"2013","unstructured":"Eaker S et al (2013) Concise review: guidance in developing commercializable autologous\/patient-specific cell therapy manufacturing. Stem Cells Transl Med 2:871\u2013883. https:\/\/doi.org\/10.5966\/sctm.2013-0050","journal-title":"Stem Cells Transl Med"},{"key":"3125_CR110","doi-asserted-by":"publisher","first-page":"2185351","DOI":"10.1155\/2017\/2185351","volume":"2017","author":"A Blazquez-Prunera","year":"2017","unstructured":"Blazquez-Prunera A, Almeida CR, Barbosa MA (2017) Human bone marrow mesenchymal stem\/stromal cells preserve their immunomodulatory and chemotactic properties when expanded in a human plasma derived xeno-free medium. Stem Cells Int 2017:2185351. https:\/\/doi.org\/10.1155\/2017\/2185351","journal-title":"Stem Cells Int"},{"key":"3125_CR111","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13287-017-0552-z","volume":"8","author":"A Blazquez-Prunera","year":"2017","unstructured":"Blazquez-Prunera A, Diez JM, Gajardo R, Grancha S (2017) Human mesenchymal stem cells maintain their phenotype, multipotentiality, and genetic stability when cultured using a defined xeno-free human plasma fraction. Stem Cell Res Ther 8:103. https:\/\/doi.org\/10.1186\/s13287-017-0552-z","journal-title":"Stem Cell Res Ther"},{"key":"3125_CR112","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s10529-013-1211-9","volume":"35","author":"QA Rafiq","year":"2013","unstructured":"Rafiq QA, Brosnan KM, Coopman K, Nienow AW, Hewitt CJ (2013) Culture of human mesenchymal stem cells on microcarriers in a 5\u00a0l stirred-tank bioreactor. Biotechnol Lett 35:1233\u20131245. https:\/\/doi.org\/10.1007\/s10529-013-1211-9","journal-title":"Biotechnol Lett"},{"key":"3125_CR113","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cryobiol.2015.07.003","volume":"71","author":"LA Marquez-Curtis","year":"2015","unstructured":"Marquez-Curtis LA, Janowska-Wieczorek A, McGann LE, Elliott JA (2015) Mesenchymal stromal cells derived from various tissues: biological, clinical and cryopreservation aspects. Cryobiology 71:181\u2013197. https:\/\/doi.org\/10.1016\/j.cryobiol.2015.07.003","journal-title":"Cryobiology"},{"key":"3125_CR114","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1002\/stem.1729","volume":"32","author":"G Moll","year":"2014","unstructured":"Moll G et al (2014) Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties? Stem Cells 32:2430\u20132442. https:\/\/doi.org\/10.1002\/stem.1729","journal-title":"Stem Cells"},{"key":"3125_CR115","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12967-016-0892-y","volume":"14","author":"C Lechanteur","year":"2016","unstructured":"Lechanteur C et al (2016) Clinical-scale expansion of mesenchymal stromal cells: a large banking experience. J Transl Med 14:145. https:\/\/doi.org\/10.1186\/s12967-016-0892-y","journal-title":"J Transl Med"},{"key":"3125_CR116","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.exphem.2006.01.002","volume":"34","author":"W Wagner","year":"2006","unstructured":"Wagner W et al (2006) The heterogeneity of human mesenchymal stem cell preparations\u2014evidence from simultaneous analysis of proteomes and transcriptomes. Exp Hematol 34:536\u2013548. https:\/\/doi.org\/10.1016\/j.exphem.2006.01.002","journal-title":"Exp Hematol"},{"key":"3125_CR117","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s12015-011-9229-7","volume":"7","author":"M Pevsner-Fischer","year":"2011","unstructured":"Pevsner-Fischer M, Levin S, Zipori D (2011) The origins of mesenchymal stromal cell heterogeneity. Stem Cell Rev 7:560\u2013568. https:\/\/doi.org\/10.1007\/s12015-011-9229-7","journal-title":"Stem Cell Rev"},{"key":"3125_CR118","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.3233\/BME-171622","volume":"28","author":"ZC Han","year":"2017","unstructured":"Han ZC, Du WJ, Han ZB, Liang L (2017) New insights into the heterogeneity and functional diversity of human mesenchymal stem cells. Biomed Mater Eng 28:S29\u2013S45. https:\/\/doi.org\/10.3233\/BME-171622","journal-title":"Biomed Mater Eng"},{"key":"3125_CR119","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1002\/jcb.24166","volume":"113","author":"DG Phinney","year":"2012","unstructured":"Phinney DG (2012) Functional heterogeneity of mesenchymal stem cells: implications for cell therapy. J Cell Biochem 113:2806\u20132812. https:\/\/doi.org\/10.1002\/jcb.24166","journal-title":"J Cell Biochem"},{"key":"3125_CR120","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.dib.2015.10.020","volume":"5","author":"ST Mindaye","year":"2015","unstructured":"Mindaye ST, Lo Surdo J, Bauer SR, Alterman MA (2015) The proteomic dataset for bone marrow derived human mesenchymal stromal cells: effect of in vitro passaging. Data Brief 5:864\u2013870. https:\/\/doi.org\/10.1016\/j.dib.2015.10.020","journal-title":"Data Brief"},{"key":"3125_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jprot.2012.10.028","volume":"78","author":"ST Mindaye","year":"2013","unstructured":"Mindaye ST, Ra M, Lo Surdo J, Bauer SR, Alterman MA (2013) Improved proteomic profiling of the cell surface of culture-expanded human bone marrow multipotent stromal cells. J Proteomics 78:1\u201314. https:\/\/doi.org\/10.1016\/j.jprot.2012.10.028","journal-title":"J Proteomics"},{"key":"3125_CR122","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.scr.2013.05.006","volume":"11","author":"ST Mindaye","year":"2013","unstructured":"Mindaye ST, Ra M, Lo Surdo JL, Bauer SR, Alterman MA (2013) Global proteomic signature of undifferentiated human bone marrow stromal cells: evidence for donor-to-donor proteome heterogeneity. Stem Cell Res 11:793\u2013805. https:\/\/doi.org\/10.1016\/j.scr.2013.05.006","journal-title":"Stem Cell Res"},{"key":"3125_CR123","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.scr.2015.09.013","volume":"15","author":"ST Mindaye","year":"2015","unstructured":"Mindaye ST, Surdo JL, Bauer SR, Alterman MA (2015) System-wide survey of proteomic responses of human bone marrow stromal cells (hBMSCs) to in vitro cultivation. Stem Cell Res 15:655\u2013664. https:\/\/doi.org\/10.1016\/j.scr.2015.09.013","journal-title":"Stem Cell Res"},{"key":"3125_CR124","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315\u2013317. https:\/\/doi.org\/10.1080\/14653240600855905","journal-title":"Cytotherapy"},{"key":"3125_CR125","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1002\/stem.1982","volume":"33","author":"RM Samsonraj","year":"2015","unstructured":"Samsonraj RM et al (2015) Establishing criteria for human mesenchymal stem cell potency. Stem Cells 33:1878\u20131891. https:\/\/doi.org\/10.1002\/stem.1982","journal-title":"Stem Cells"},{"key":"3125_CR126","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/stem.1681","volume":"32","author":"FJ Lv","year":"2014","unstructured":"Lv FJ, Tuan RS, Cheung KM, Leung VY (2014) Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells 32:1408\u20131419. https:\/\/doi.org\/10.1002\/stem.1681","journal-title":"Stem Cells"},{"key":"3125_CR127","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/stem.2296","volume":"34","author":"DA Rennerfeldt","year":"2016","unstructured":"Rennerfeldt DA, Van Vliet KJ (2016) Concise review: when colonies are not clones: evidence and implications of intracolony heterogeneity in mesenchymal stem cells. Stem Cells 34:1135\u20131141. https:\/\/doi.org\/10.1002\/stem.2296","journal-title":"Stem Cells"},{"key":"3125_CR128","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.exphem.2004.03.013","volume":"32","author":"J Cai","year":"2004","unstructured":"Cai J, Weiss ML, Rao MS (2004) In search of \u201cstemness\u201d. Exp Hematol 32:585\u2013598. https:\/\/doi.org\/10.1016\/j.exphem.2004.03.013","journal-title":"Exp Hematol"},{"key":"3125_CR129","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1089\/107632704323061753","volume":"10","author":"J De Boer","year":"2004","unstructured":"De Boer J, Wang HJ, Van Blitterswijk C (2004) Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Tissue Eng 10:393\u2013401. https:\/\/doi.org\/10.1089\/107632704323061753","journal-title":"Tissue Eng"},{"key":"3125_CR130","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/j.1474-9726.2007.00336.x","volume":"6","author":"C Fehrer","year":"2007","unstructured":"Fehrer C et al (2007) Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell 6:745\u2013757. https:\/\/doi.org\/10.1111\/j.1474-9726.2007.00336.x","journal-title":"Aging Cell"},{"key":"3125_CR131","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/cdd.2011.172","volume":"19","author":"JC Estrada","year":"2012","unstructured":"Estrada JC et al (2012) Culture of human mesenchymal stem cells at low oxygen tension improves growth and genetic stability by activating glycolysis. Cell Death Differ 19:743\u2013755. https:\/\/doi.org\/10.1038\/cdd.2011.172","journal-title":"Cell Death Differ"},{"key":"3125_CR132","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/sj.leu.2402962","volume":"17","author":"S Zimmermann","year":"2003","unstructured":"Zimmermann S et al (2003) Lack of telomerase activity in human mesenchymal stem cells. Leukemia 17:1146\u20131149. https:\/\/doi.org\/10.1038\/sj.leu.2402962","journal-title":"Leukemia"},{"key":"3125_CR133","doi-asserted-by":"publisher","first-page":"9142","DOI":"10.1158\/0008-5472.CAN-06-4690","volume":"67","author":"ME Bernardo","year":"2007","unstructured":"Bernardo ME et al (2007) Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 67:9142\u20139149. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-4690","journal-title":"Cancer Res"},{"key":"3125_CR134","doi-asserted-by":"publisher","first-page":"e2213","DOI":"10.1371\/journal.pone.0002213","volume":"3","author":"W Wagner","year":"2008","unstructured":"Wagner W et al (2008) Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 3:e2213. https:\/\/doi.org\/10.1371\/journal.pone.0002213","journal-title":"PLoS One"},{"key":"3125_CR135","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1474-9726.2009.00535.x","volume":"9","author":"S Bork","year":"2010","unstructured":"Bork S et al (2010) DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 9:54\u201363. https:\/\/doi.org\/10.1111\/j.1474-9726.2009.00535.x","journal-title":"Aging Cell"},{"key":"3125_CR136","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.3390\/ijms17071164","volume":"17","author":"V Turinetto","year":"2016","unstructured":"Turinetto V, Vitale E, Giachino C (2016) Senescence in human mesenchymal stem cells: functional changes and implications in stem cell-based therapy. Int J Mol Sci 17:1164. https:\/\/doi.org\/10.3390\/ijms17071164","journal-title":"Int J Mol Sci"},{"key":"3125_CR137","doi-asserted-by":"publisher","first-page":"9645","DOI":"10.1074\/jbc.275.13.9645","volume":"275","author":"RK Jaiswal","year":"2000","unstructured":"Jaiswal RK et al (2000) Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem 275:9645\u20139652","journal-title":"J Biol Chem"},{"key":"3125_CR138","doi-asserted-by":"publisher","first-page":"5158","DOI":"10.1016\/j.biomaterials.2005.01.002","volume":"26","author":"WJ Li","year":"2005","unstructured":"Li WJ, Tuli R, Huang X, Laquerriere P, Tuan RS (2005) Multilineage differentiation of human mesenchymal stem cells in a three-dimensional nanofibrous scaffold. Biomaterials 26:5158\u20135166. https:\/\/doi.org\/10.1016\/j.biomaterials.2005.01.002","journal-title":"Biomaterials"},{"key":"3125_CR139","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/cdd.2015.168","volume":"23","author":"Q Chen","year":"2016","unstructured":"Chen Q et al (2016) Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? Cell Death Differ 23:1128\u20131139. https:\/\/doi.org\/10.1038\/cdd.2015.168","journal-title":"Cell Death Differ"},{"key":"3125_CR140","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nrm3198","volume":"12","author":"AG Cristancho","year":"2011","unstructured":"Cristancho AG, Lazar MA (2011) Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 12:722\u2013734. https:\/\/doi.org\/10.1038\/nrm3198","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"Suppl 1","key":"3125_CR141","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.injury.2008.01.038","volume":"39","author":"K Pelttari","year":"2008","unstructured":"Pelttari K, Steck E, Richter W (2008) The use of mesenchymal stem cells for chondrogenesis. Injury 39(Suppl 1):S58\u2013S65. https:\/\/doi.org\/10.1016\/j.injury.2008.01.038","journal-title":"Injury"},{"key":"3125_CR142","doi-asserted-by":"publisher","first-page":"41227","DOI":"10.1074\/jbc.M305312200","volume":"278","author":"R Tuli","year":"2003","unstructured":"Tuli R et al (2003) Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. J Biol Chem 278:41227\u201341236. https:\/\/doi.org\/10.1074\/jbc.M305312200","journal-title":"J Biol Chem"},{"key":"3125_CR143","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.bbrc.2006.02.171","volume":"343","author":"M Chiou","year":"2006","unstructured":"Chiou M, Xu Y, Longaker MT (2006) Mitogenic and chondrogenic effects of fibroblast growth factor-2 in adipose-derived mesenchymal cells. Biochem Biophys Res Commun 343:644\u2013652. https:\/\/doi.org\/10.1016\/j.bbrc.2006.02.171","journal-title":"Biochem Biophys Res Commun"},{"key":"3125_CR144","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1359\/jbmr.051213","volume":"21","author":"L Longobardi","year":"2006","unstructured":"Longobardi L et al (2006) Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res 21:626\u2013636. https:\/\/doi.org\/10.1359\/jbmr.051213","journal-title":"J Bone Miner Res"},{"key":"3125_CR145","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1432-0436.2003.07109003.x","volume":"71","author":"B Schmitt","year":"2003","unstructured":"Schmitt B et al (2003) BMP2 initiates chondrogenic lineage development of adult human mesenchymal stem cells in high-density culture. Differentiation 71:567\u2013577. https:\/\/doi.org\/10.1111\/j.1432-0436.2003.07109003.x","journal-title":"Differentiation"},{"key":"3125_CR146","doi-asserted-by":"publisher","first-page":"e1002356","DOI":"10.1371\/journal.pgen.1002356","volume":"7","author":"VY Leung","year":"2011","unstructured":"Leung VY et al (2011) SOX9 governs differentiation stage-specific gene expression in growth plate chondrocytes via direct concomitant transactivation and repression. PLoS Genet 7:e1002356. https:\/\/doi.org\/10.1371\/journal.pgen.1002356","journal-title":"PLoS Genet"},{"key":"3125_CR147","doi-asserted-by":"publisher","first-page":"8343","DOI":"10.1074\/jbc.M413913200","volume":"280","author":"T Furumatsu","year":"2005","unstructured":"Furumatsu T, Tsuda M, Taniguchi N, Tajima Y, Asahara H (2005) Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein\/p300 recruitment. J Biol Chem 280:8343\u20138350. https:\/\/doi.org\/10.1074\/jbc.M413913200","journal-title":"J Biol Chem"},{"key":"3125_CR148","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.bbrc.2004.06.029","volume":"320","author":"N Indrawattana","year":"2004","unstructured":"Indrawattana N et al (2004) Growth factor combination for chondrogenic induction from human mesenchymal stem cell. Biochem Biophys Res Commun 320:914\u2013919. https:\/\/doi.org\/10.1016\/j.bbrc.2004.06.029","journal-title":"Biochem Biophys Res Commun"},{"key":"3125_CR149","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/jcb.20719","volume":"98","author":"MS Friedman","year":"2006","unstructured":"Friedman MS, Long MW, Hankenson KD (2006) Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J Cell Biochem 98:538\u2013554. https:\/\/doi.org\/10.1002\/jcb.20719","journal-title":"J Cell Biochem"},{"key":"3125_CR150","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3892\/ijmm.2017.2872","volume":"39","author":"K Marupanthorn","year":"2017","unstructured":"Marupanthorn K, Tantrawatpan C, Kheolamai P, Tantikanlayaporn D, Manochantr S (2017) Bone morphogenetic protein-2 enhances the osteogenic differentiation capacity of mesenchymal stromal cells derived from human bone marrow and umbilical cord. Int J Mol Med 39:654\u2013662. https:\/\/doi.org\/10.3892\/ijmm.2017.2872","journal-title":"Int J Mol Med"},{"key":"3125_CR151","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00441-004-1075-3","volume":"320","author":"I Sekiya","year":"2005","unstructured":"Sekiya I, Larson BL, Vuoristo JT, Reger RL, Prockop DJ (2005) Comparison of effect of BMP-2, -4, and -6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma. Cell Tissue Res 320:269\u2013276. https:\/\/doi.org\/10.1007\/s00441-004-1075-3","journal-title":"Cell Tissue Res"},{"key":"3125_CR152","doi-asserted-by":"publisher","first-page":"31353","DOI":"10.1074\/jbc.M503845200","volume":"280","author":"AB Celil","year":"2005","unstructured":"Celil AB, Campbell PG (2005) BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J Biol Chem 280:31353\u201331359","journal-title":"J Biol Chem"},{"key":"3125_CR153","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0092-8674(01)00622-5","volume":"108","author":"K Nakashima","year":"2002","unstructured":"Nakashima K et al (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17\u201329","journal-title":"Cell"},{"key":"3125_CR154","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.gene.2005.12.022","volume":"372","author":"Y Nishio","year":"2006","unstructured":"Nishio Y et al (2006) Runx2-mediated regulation of the zinc finger Osterix\/Sp7 gene. Gene 372:62\u201370","journal-title":"Gene"},{"key":"3125_CR155","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1002\/jcb.23287","volume":"112","author":"GL Lin","year":"2011","unstructured":"Lin GL, Hankenson KD (2011) Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. J Cell Biochem 112:3491\u20133501","journal-title":"J Cell Biochem"},{"key":"3125_CR156","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1634\/stemcells.2007-0974","volume":"26","author":"C Fontaine","year":"2008","unstructured":"Fontaine C, Cousin W, Plaisant M, Dani C, Peraldi P (2008) Hedgehog signaling alters adipocyte maturation of human mesenchymal stem cells. Stem Cells 26:1037\u20131046. https:\/\/doi.org\/10.1634\/stemcells.2007-0974","journal-title":"Stem Cells"},{"key":"3125_CR157","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1634\/stemcells.2007-0806","volume":"26","author":"RA Oldershaw","year":"2008","unstructured":"Oldershaw RA et al (2008) Notch signaling through Jagged-1 is necessary to initiate chondrogenesis in human bone marrow stromal cells but must be switched off to complete chondrogenesis. Stem Cells 26:666\u2013674. https:\/\/doi.org\/10.1634\/stemcells.2007-0806","journal-title":"Stem Cells"},{"key":"3125_CR158","doi-asserted-by":"publisher","first-page":"e46842","DOI":"10.1371\/journal.pone.0046842","volume":"7","author":"K Janeczek Portalska","year":"2012","unstructured":"Janeczek Portalska K et al (2012) Endothelial differentiation of mesenchymal stromal cells. PLoS One 7:e46842. https:\/\/doi.org\/10.1371\/journal.pone.0046842","journal-title":"PLoS One"},{"key":"3125_CR159","doi-asserted-by":"publisher","first-page":"e00191","DOI":"10.1042\/bsr20150025","volume":"35","author":"I Ullah","year":"2015","unstructured":"Ullah I, Subbarao RB, Rho GJ (2015) Human mesenchymal stem cells\u2014current trends and future prospective. Biosci Rep 35:e00191. https:\/\/doi.org\/10.1042\/bsr20150025","journal-title":"Biosci Rep"},{"key":"3125_CR160","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1042\/CBI20100417","volume":"35","author":"JP Beier","year":"2011","unstructured":"Beier JP et al (2011) Myogenic differentiation of mesenchymal stem cells co-cultured with primary myoblasts. Cell Biol Int 35:397\u2013406. https:\/\/doi.org\/10.1042\/CBI20100417","journal-title":"Cell Biol Int"},{"key":"3125_CR161","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1096\/fj.03-1100fje","volume":"18","author":"L Song","year":"2004","unstructured":"Song L, Tuan RS (2004) Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J 18:980\u2013982. https:\/\/doi.org\/10.1096\/fj.03-1100fje","journal-title":"FASEB J"},{"key":"3125_CR162","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-bioeng-070909-105309","volume":"12","author":"B Parekkadan","year":"2010","unstructured":"Parekkadan B, Milwid JM (2010) Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng 12:87\u2013117. https:\/\/doi.org\/10.1146\/annurev-bioeng-070909-105309","journal-title":"Annu Rev Biomed Eng"},{"key":"3125_CR163","doi-asserted-by":"publisher","first-page":"8932","DOI":"10.1073\/pnas.132252399","volume":"99","author":"EM Horwitz","year":"2002","unstructured":"Horwitz EM et al (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99:8932\u20138937. https:\/\/doi.org\/10.1073\/pnas.132252399","journal-title":"Proc Natl Acad Sci USA"},{"key":"3125_CR164","doi-asserted-by":"publisher","first-page":"732742","DOI":"10.1155\/2013\/732742","volume":"2013","author":"TJ Kean","year":"2013","unstructured":"Kean TJ, Lin P, Caplan AI, Dennis JE (2013) MSCs: delivery routes and engraftment, cell-targeting strategies, and immune modulation. Stem Cells Int 2013:732742. https:\/\/doi.org\/10.1155\/2013\/732742","journal-title":"Stem Cells Int"},{"key":"3125_CR165","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1634\/stemcells.20-4-279","volume":"20","author":"M Tomita","year":"2002","unstructured":"Tomita M et al (2002) Bone marrow-derived stem cells can differentiate into retinal cells in injured rat retina. Stem Cells 20:279\u2013283. https:\/\/doi.org\/10.1634\/stemcells.20-4-279","journal-title":"Stem Cells"},{"key":"3125_CR166","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.exer.2007.04.007","volume":"85","author":"Y Inoue","year":"2007","unstructured":"Inoue Y et al (2007) Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration. Exp Eye Res 85:234\u2013241. https:\/\/doi.org\/10.1016\/j.exer.2007.04.007","journal-title":"Exp Eye Res"},{"key":"3125_CR167","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13287-016-0432-y","volume":"7","author":"A Oner","year":"2016","unstructured":"Oner A, Gonen ZB, Sinim N, Cetin M, Ozkul Y (2016) Subretinal adipose tissue-derived mesenchymal stem cell implantation in advanced stage retinitis pigmentosa: a phase I clinical safety study. Stem Cell Res Ther 7:178. https:\/\/doi.org\/10.1186\/s13287-016-0432-y","journal-title":"Stem Cell Res Ther"},{"key":"3125_CR168","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/2008-322X.200164","volume":"12","author":"L Satarian","year":"2017","unstructured":"Satarian L et al (2017) Intravitreal injection of bone marrow mesenchymal stem cells in patients with advanced retinitis pigmentosa; a safety study. J Ophthalmic Vis Res 12:58\u201364. https:\/\/doi.org\/10.4103\/2008-322X.200164","journal-title":"J Ophthalmic Vis Res"},{"key":"3125_CR169","doi-asserted-by":"publisher","first-page":"46913","DOI":"10.18632\/oncotarget.10442","volume":"7","author":"PG Limoli","year":"2016","unstructured":"Limoli PG, Limoli C, Vingolo EM, Scalinci SZ, Nebbioso M (2016) Cell surgery and growth factors in dry age-related macular degeneration: visual prognosis and morphological study. Oncotarget 7:46913\u201346923. https:\/\/doi.org\/10.18632\/oncotarget.10442","journal-title":"Oncotarget"},{"key":"3125_CR170","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S1474-4422(11)70121-1","volume":"10","author":"A Uccelli","year":"2011","unstructured":"Uccelli A, Laroni A, Freedman MS (2011) Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases. Lancet Neurol 10:649\u2013656. https:\/\/doi.org\/10.1016\/S1474-4422(11)70121-1","journal-title":"Lancet Neurol"},{"key":"3125_CR171","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S1474-4422(11)70305-2","volume":"11","author":"P Connick","year":"2012","unstructured":"Connick P et al (2012) Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol 11:150\u2013156. https:\/\/doi.org\/10.1016\/S1474-4422(11)70305-2","journal-title":"Lancet Neurol"},{"key":"3125_CR172","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1146\/annurev.med.59.061506.154239","volume":"59","author":"BD Humphreys","year":"2008","unstructured":"Humphreys BD, Bonventre JV (2008) Mesenchymal stem cells in acute kidney injury. Annu Rev Med 59:311\u2013325. https:\/\/doi.org\/10.1146\/annurev.med.59.061506.154239","journal-title":"Annu Rev Med"},{"key":"3125_CR173","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1161\/CIRCRESAHA.116.303614","volume":"116","author":"V Karantalis","year":"2015","unstructured":"Karantalis V, Hare JM (2015) Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res 116:1413\u20131430. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303614","journal-title":"Circ Res"},{"key":"3125_CR174","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/stem.556","volume":"29","author":"V Volarevic","year":"2011","unstructured":"Volarevic V, Arsenijevic N, Lukic ML, Stojkovic M (2011) Concise review: mesenchymal stem cell treatment of the complications of diabetes mellitus. Stem Cells 29:5\u201310. https:\/\/doi.org\/10.1002\/stem.556","journal-title":"Stem Cells"},{"key":"3125_CR175","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1053\/j.gastro.2008.03.015","volume":"134","author":"TK Kuo","year":"2008","unstructured":"Kuo TK et al (2008) Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 134:2111\u20132121. https:\/\/doi.org\/10.1053\/j.gastro.2008.03.015 (2121 e2111\u20132113)","journal-title":"Gastroenterology"},{"key":"3125_CR176","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/MOT.0b013e328317a462","volume":"13","author":"I Muller","year":"2008","unstructured":"Muller I, Lymperi S, Dazzi F (2008) Mesenchymal stem cell therapy for degenerative inflammatory disorders. Curr Opin Organ Transplant 13:639\u2013644. https:\/\/doi.org\/10.1097\/MOT.0b013e328317a462","journal-title":"Curr Opin Organ Transplant"},{"key":"3125_CR177","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/stem.1118","volume":"30","author":"L von Bahr","year":"2012","unstructured":"von Bahr L et al (2012) Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation. Stem Cells 30:1575\u20131578. https:\/\/doi.org\/10.1002\/stem.1118","journal-title":"Stem Cells"},{"key":"3125_CR178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15283\/ijsc.2008.1.1.1","volume":"1","author":"A Kurtz","year":"2008","unstructured":"Kurtz A (2008) Mesenchymal stem cell delivery routes and fate. Int J Stem Cells 1:1\u20137","journal-title":"Int J Stem Cells"},{"key":"3125_CR179","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/jcp.21200","volume":"213","author":"AI Caplan","year":"2007","unstructured":"Caplan AI (2007) Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213:341\u2013347. https:\/\/doi.org\/10.1002\/jcp.21200","journal-title":"J Cell Physiol"},{"key":"3125_CR180","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/ar614","volume":"5","author":"RS Tuan","year":"2003","unstructured":"Tuan RS, Boland G, Tuli R (2003) Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 5:32\u201345","journal-title":"Arthritis Res Ther"},{"key":"3125_CR181","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1021\/acsbiomaterials.6b00741","volume":"4","author":"JK Leach","year":"2018","unstructured":"Leach JK, Whitehead J (2018) Materials-directed differentiation of mesenchymal stem cells for tissue engineering and regeneration. ACS Biomater Sci Eng 4:1115\u20131127. https:\/\/doi.org\/10.1021\/acsbiomaterials.6b00741","journal-title":"ACS Biomater Sci Eng"},{"key":"3125_CR182","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1089\/ten.TEB.2012.0437","volume":"19","author":"QL Loh","year":"2013","unstructured":"Loh QL, Choong C (2013) Three-dimensional scaffolds for tissue engineering applications: role of porosity and pore size. Tissue Eng Part B Rev 19:485\u2013502. https:\/\/doi.org\/10.1089\/ten.TEB.2012.0437","journal-title":"Tissue Eng Part B Rev"},{"key":"3125_CR183","doi-asserted-by":"publisher","first-page":"5744","DOI":"10.3390\/ma8095273","volume":"8","author":"Z Sheikh","year":"2015","unstructured":"Sheikh Z et al (2015) Biodegradable materials for bone repair and tissue engineering applications. Materials (Basel) 8:5744\u20135794. https:\/\/doi.org\/10.3390\/ma8095273","journal-title":"Materials (Basel)"},{"key":"3125_CR184","doi-asserted-by":"publisher","first-page":"035002","DOI":"10.1088\/1758-5090\/8\/3\/035002","volume":"8","author":"M Costantini","year":"2016","unstructured":"Costantini M et al (2016) 3D bioprinting of BM-MSCs-loaded ECM biomimetic hydrogels for in vitro neocartilage formation. Biofabrication 8:035002. https:\/\/doi.org\/10.1088\/1758-5090\/8\/3\/035002","journal-title":"Biofabrication"},{"key":"3125_CR185","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1089\/ten.TEB.2014.0090","volume":"20","author":"T Aoyama","year":"2014","unstructured":"Aoyama T et al (2014) An exploratory clinical trial for idiopathic osteonecrosis of femoral head by cultured autologous multipotent mesenchymal stromal cells augmented with vascularized bone grafts. Tissue Eng Part B Rev 20:233\u2013242. https:\/\/doi.org\/10.1089\/ten.TEB.2014.0090","journal-title":"Tissue Eng Part B Rev"},{"key":"3125_CR186","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13287-018-0951-9","volume":"9","author":"C Gjerde","year":"2018","unstructured":"Gjerde C et al (2018) Cell therapy induced regeneration of severely atrophied mandibular bone in a clinical trial. Stem Cell Res Ther 9:213. https:\/\/doi.org\/10.1186\/s13287-018-0951-9","journal-title":"Stem Cell Res Ther"},{"key":"3125_CR187","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1634\/stemcells.2007-0068","volume":"25","author":"F Benvenuto","year":"2007","unstructured":"Benvenuto F et al (2007) Human mesenchymal stem cells promote survival of T cells in a quiescent state. Stem Cells 25:1753\u20131760. https:\/\/doi.org\/10.1634\/stemcells.2007-0068","journal-title":"Stem Cells"},{"key":"3125_CR188","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature12984","volume":"505","author":"SJ Morrison","year":"2014","unstructured":"Morrison SJ, Scadden DT (2014) The bone marrow niche for haematopoietic stem cells. Nature 505:327\u2013334. https:\/\/doi.org\/10.1038\/nature12984","journal-title":"Nature"},{"key":"3125_CR189","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1089\/152581600750062264","volume":"9","author":"MK Majumdar","year":"2000","unstructured":"Majumdar MK, Thiede MA, Haynesworth SE, Bruder SP, Gerson SL (2000) Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 9:841\u2013848. https:\/\/doi.org\/10.1089\/152581600750062264","journal-title":"J Hematother Stem Cell Res"},{"key":"3125_CR190","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13287-016-0394-0","volume":"7","author":"HR Hofer","year":"2016","unstructured":"Hofer HR, Tuan RS (2016) Secreted trophic factors of mesenchymal stem cells support neurovascular and musculoskeletal therapies. Stem Cell Res Ther 7:131. https:\/\/doi.org\/10.1186\/s13287-016-0394-0","journal-title":"Stem Cell Res Ther"},{"key":"3125_CR191","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nature11926","volume":"495","author":"A Greenbaum","year":"2013","unstructured":"Greenbaum A et al (2013) CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature 495:227\u2013230. https:\/\/doi.org\/10.1038\/nature11926","journal-title":"Nature"},{"key":"3125_CR192","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1200\/JCO.2000.18.2.307","volume":"18","author":"ON Koc","year":"2000","unstructured":"Koc ON et al (2000) Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18:307\u2013316. https:\/\/doi.org\/10.1200\/JCO.2000.18.2.307","journal-title":"J Clin Oncol"},{"key":"3125_CR193","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/bmb\/ldt031","volume":"108","author":"SM Watt","year":"2013","unstructured":"Watt SM et al (2013) The angiogenic properties of mesenchymal stem\/stromal cells and their therapeutic potential. Br Med Bull 108:25\u201353. https:\/\/doi.org\/10.1093\/bmb\/ldt031","journal-title":"Br Med Bull"},{"key":"3125_CR194","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2007.08.025","volume":"131","author":"B Sacchetti","year":"2007","unstructured":"Sacchetti B et al (2007) Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131:324\u2013336. https:\/\/doi.org\/10.1016\/j.cell.2007.08.025","journal-title":"Cell"},{"key":"3125_CR195","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/mt.2016.12","volume":"24","author":"K Pollock","year":"2016","unstructured":"Pollock K et al (2016) Human mesenchymal stem cells genetically engineered to overexpress brain-derived neurotrophic factor improve outcomes in huntington\u2019s disease mouse models. Mol Ther 24:965\u2013977. https:\/\/doi.org\/10.1038\/mt.2016.12","journal-title":"Mol Ther"},{"key":"3125_CR196","doi-asserted-by":"publisher","first-page":"18171","DOI":"10.1073\/pnas.0508945102","volume":"102","author":"JR Munoz","year":"2005","unstructured":"Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ (2005) Human stem\/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci USA 102:18171\u201318176. https:\/\/doi.org\/10.1073\/pnas.0508945102","journal-title":"Proc Natl Acad Sci USA"},{"key":"3125_CR197","doi-asserted-by":"publisher","first-page":"933","DOI":"10.2217\/rme.10.72","volume":"5","author":"N Joyce","year":"2010","unstructured":"Joyce N et al (2010) Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med 5:933\u2013946. https:\/\/doi.org\/10.2217\/rme.10.72","journal-title":"Regen Med"},{"key":"3125_CR198","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.expneurol.2005.10.029","volume":"198","author":"L Crigler","year":"2006","unstructured":"Crigler L, Robey RC, Asawachaicharn A, Gaupp D, Phinney DG (2006) Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 198:54\u201364. https:\/\/doi.org\/10.1016\/j.expneurol.2005.10.029","journal-title":"Exp Neurol"},{"key":"3125_CR199","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.expneurol.2007.10.011","volume":"210","author":"MK McCoy","year":"2008","unstructured":"McCoy MK et al (2008) Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson\u2019s disease. Exp Neurol 210:14\u201329. https:\/\/doi.org\/10.1016\/j.expneurol.2007.10.011","journal-title":"Exp Neurol"},{"key":"3125_CR200","doi-asserted-by":"publisher","first-page":"e22924","DOI":"10.1371\/journal.pone.0022924","volume":"6","author":"YT Lin","year":"2011","unstructured":"Lin YT et al (2011) Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington\u2019s disease mouse models. PLoS One 6:e22924. https:\/\/doi.org\/10.1371\/journal.pone.0022924","journal-title":"PLoS One"},{"key":"3125_CR201","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/jnr.22279","volume":"88","author":"K Wakabayashi","year":"2010","unstructured":"Wakabayashi K et al (2010) Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. J Neurosci Res 88:1017\u20131025. https:\/\/doi.org\/10.1002\/jnr.22279","journal-title":"J Neurosci Res"},{"key":"3125_CR202","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.scr.2009.02.006","volume":"3","author":"A Wilkins","year":"2009","unstructured":"Wilkins A et al (2009) Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. Stem Cell Res 3:63\u201370. https:\/\/doi.org\/10.1016\/j.scr.2009.02.006","journal-title":"Stem Cell Res"},{"key":"3125_CR203","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3727\/096368913X673450","volume":"23","author":"KS Kim","year":"2014","unstructured":"Kim KS et al (2014) Transplantation of human adipose tissue-derived stem cells delays clinical onset and prolongs life span in ALS mouse model. Cell Transplant 23:1585\u20131597. https:\/\/doi.org\/10.3727\/096368913X673450","journal-title":"Cell Transplant"},{"key":"3125_CR204","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1002\/stem.1770","volume":"32","author":"HY Kim","year":"2014","unstructured":"Kim HY et al (2014) Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study. Stem Cells 32:2724\u20132731. https:\/\/doi.org\/10.1002\/stem.1770","journal-title":"Stem Cells"},{"key":"3125_CR205","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/jamaneurol.2015.4321","volume":"73","author":"P Petrou","year":"2016","unstructured":"Petrou P et al (2016) Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1\/2 and 2a clinical trials. JAMA Neurol 73:337\u2013344. https:\/\/doi.org\/10.1001\/jamaneurol.2015.4321","journal-title":"JAMA Neurol"},{"key":"3125_CR206","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1002\/stem.1818","volume":"32","author":"V Volarevic","year":"2014","unstructured":"Volarevic V, Nurkovic J, Arsenijevic N, Stojkovic M (2014) Concise review: therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis. Stem Cells 32:2818\u20132823. https:\/\/doi.org\/10.1002\/stem.1818","journal-title":"Stem Cells"},{"key":"3125_CR207","doi-asserted-by":"publisher","first-page":"17438","DOI":"10.1073\/pnas.0608249103","volume":"103","author":"RH Lee","year":"2006","unstructured":"Lee RH et al (2006) Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD\/scid mice. Proc Natl Acad Sci USA 103:17438\u201317443. https:\/\/doi.org\/10.1073\/pnas.0608249103","journal-title":"Proc Natl Acad Sci USA"},{"key":"3125_CR208","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1093\/ndt\/gfs556","volume":"28","author":"M Morigi","year":"2013","unstructured":"Morigi M, Benigni A (2013) Mesenchymal stem cells and kidney repair. Nephrol Dial Transplant 28:788\u2013793. https:\/\/doi.org\/10.1093\/ndt\/gfs556","journal-title":"Nephrol Dial Transplant"},{"key":"3125_CR209","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-1-4939-3584-0_5","volume":"1416","author":"M Morigi","year":"2016","unstructured":"Morigi M, Rota C, Remuzzi G (2016) Mesenchymal stem cells in kidney repair. Methods Mol Biol 1416:89\u2013107. https:\/\/doi.org\/10.1007\/978-1-4939-3584-0_5","journal-title":"Methods Mol Biol"},{"key":"3125_CR210","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13287-018-0814-4","volume":"9","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Li Y, Zhang L, Li J, Zhu C (2018) Mesenchymal stem cells: potential application for the treatment of hepatic cirrhosis. Stem Cell Res Ther 9:59. https:\/\/doi.org\/10.1186\/s13287-018-0814-4","journal-title":"Stem Cell Res Ther"},{"key":"3125_CR211","doi-asserted-by":"publisher","first-page":"e38189","DOI":"10.1371\/journal.pone.0038189","volume":"7","author":"TY Yeung","year":"2012","unstructured":"Yeung TY et al (2012) Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines. PLoS One 7:e38189. https:\/\/doi.org\/10.1371\/journal.pone.0038189","journal-title":"PLoS One"},{"key":"3125_CR212","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/TP.0b013e3181c7dc99","volume":"89","author":"KS Park","year":"2010","unstructured":"Park KS et al (2010) Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation. Transplantation 89:509\u2013517. https:\/\/doi.org\/10.1097\/TP.0b013e3181c7dc99","journal-title":"Transplantation"},{"key":"3125_CR213","doi-asserted-by":"publisher","first-page":"e1886","DOI":"10.1371\/journal.pone.0001886","volume":"3","author":"L Chen","year":"2008","unstructured":"Chen L, Tredget EE, Wu PY, Wu Y (2008) Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 3:e1886. https:\/\/doi.org\/10.1371\/journal.pone.0001886","journal-title":"PLoS One"},{"key":"3125_CR214","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.amjcard.2004.03.034","volume":"94","author":"SL Chen","year":"2004","unstructured":"Chen SL et al (2004) Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94:92\u201395. https:\/\/doi.org\/10.1016\/j.amjcard.2004.03.034","journal-title":"Am J Cardiol"},{"key":"3125_CR215","doi-asserted-by":"publisher","first-page":"11474","DOI":"10.1073\/pnas.0504388102","volume":"102","author":"LC Amado","year":"2005","unstructured":"Amado LC et al (2005) Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 102:11474\u201311479. https:\/\/doi.org\/10.1073\/pnas.0504388102","journal-title":"Proc Natl Acad Sci USA"},{"key":"3125_CR216","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/01.RES.0000118601.37875.AC","volume":"94","author":"T Kinnaird","year":"2004","unstructured":"Kinnaird T et al (2004) Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94:678\u2013685. https:\/\/doi.org\/10.1161\/01.RES.0000118601.37875.AC","journal-title":"Circ Res"},{"key":"3125_CR217","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1161\/01.CIR.0000124062.31102.57","volume":"109","author":"T Kinnaird","year":"2004","unstructured":"Kinnaird T et al (2004) Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109:1543\u20131549. https:\/\/doi.org\/10.1161\/01.CIR.0000124062.31102.57","journal-title":"Circulation"},{"key":"3125_CR218","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.stem.2012.02.005","volume":"10","author":"SH Ranganath","year":"2012","unstructured":"Ranganath SH, Levy O, Inamdar MS, Karp JM (2012) Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 10:244\u2013258. https:\/\/doi.org\/10.1016\/j.stem.2012.02.005","journal-title":"Cell Stem Cell"},{"key":"3125_CR219","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jcb.24377","volume":"114","author":"XJ Guan","year":"2013","unstructured":"Guan XJ et al (2013) Mesenchymal stem cells protect cigarette smoke-damaged lung and pulmonary function partly via VEGF-VEGF receptors. J Cell Biochem 114:323\u2013335. https:\/\/doi.org\/10.1002\/jcb.24377","journal-title":"J Cell Biochem"},{"key":"3125_CR220","doi-asserted-by":"publisher","first-page":"38207","DOI":"10.1038\/srep38207","volume":"6","author":"H Kennelly","year":"2016","unstructured":"Kennelly H, Mahon BP, English K (2016) Human mesenchymal stromal cells exert HGF dependent cytoprotective effects in a human relevant pre-clinical model of COPD. Sci Rep 6:38207. https:\/\/doi.org\/10.1038\/srep38207","journal-title":"Sci Rep"},{"key":"3125_CR221","doi-asserted-by":"publisher","first-page":"352","DOI":"10.5581\/1516-8484.20130113","volume":"35","author":"T Stessuk","year":"2013","unstructured":"Stessuk T et al (2013) Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years. Rev Bras Hematol Hemoter 35:352\u2013357. https:\/\/doi.org\/10.5581\/1516-8484.20130113","journal-title":"Rev Bras Hematol Hemoter"},{"key":"3125_CR222","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/sctm.16-0315","volume":"6","author":"HG de Oliveira","year":"2017","unstructured":"de Oliveira HG et al (2017) Combined bone marrow-derived mesenchymal stromal cell therapy and one-way endobronchial valve placement in patients with pulmonary emphysema: a phase I clinical trial. Stem Cells Transl Med 6:962\u2013969. https:\/\/doi.org\/10.1002\/sctm.16-0315","journal-title":"Stem Cells Transl Med"},{"key":"3125_CR223","doi-asserted-by":"publisher","first-page":"845","DOI":"10.5966\/sctm.2015-0021erratum","volume":"5","author":"OE Simonson","year":"2016","unstructured":"Simonson OE et al (2016) In vivo effects of mesenchymal stromal cells in two patients with severe acute respiratory distress syndrome. Stem Cells Transl Med 5:845. https:\/\/doi.org\/10.5966\/sctm.2015-0021erratum","journal-title":"Stem Cells Transl Med"},{"key":"3125_CR224","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.stem.2009.02.001","volume":"4","author":"JM Karp","year":"2009","unstructured":"Karp JM, Leng Teo GS (2009) Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 4:206\u2013216. https:\/\/doi.org\/10.1016\/j.stem.2009.02.001","journal-title":"Cell Stem Cell"},{"key":"3125_CR225","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fimmu.2014.00148","volume":"5","author":"E Eggenhofer","year":"2014","unstructured":"Eggenhofer E, Luk F, Dahlke MH, Hoogduijn MJ (2014) The life and fate of mesenchymal stem cells. Front Immunol 5:148. https:\/\/doi.org\/10.3389\/fimmu.2014.00148","journal-title":"Front Immunol"},{"key":"3125_CR226","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13287-016-0420-2","volume":"7","author":"M Li","year":"2016","unstructured":"Li M et al (2016) In vivo human adipose-derived mesenchymal stem cell tracking after intra-articular delivery in a rat osteoarthritis model. Stem Cell Res Ther 7:160. https:\/\/doi.org\/10.1186\/s13287-016-0420-2","journal-title":"Stem Cell Res Ther"},{"key":"3125_CR227","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/sctm.17-0209","volume":"7","author":"A Brooks","year":"2018","unstructured":"Brooks A et al (2018) Concise review: quantitative detection and modeling the in vivo kinetics of therapeutic mesenchymal stem\/stromal cells. Stem Cells Transl Med 7:78\u201386. https:\/\/doi.org\/10.1002\/sctm.17-0209","journal-title":"Stem Cells Transl Med"},{"key":"3125_CR228","doi-asserted-by":"publisher","first-page":"130763","DOI":"10.1155\/2013\/130763","volume":"2013","author":"A Sohni","year":"2013","unstructured":"Sohni A, Verfaillie CM (2013) Mesenchymal stem cells migration homing and tracking. Stem Cells Int 2013:130763. https:\/\/doi.org\/10.1155\/2013\/130763","journal-title":"Stem Cells Int"},{"key":"3125_CR229","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1182\/blood-2006-05-025098","volume":"108","author":"B Ruster","year":"2006","unstructured":"Ruster B et al (2006) Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 108:3938\u20133944. https:\/\/doi.org\/10.1182\/blood-2006-05-025098","journal-title":"Blood"},{"key":"3125_CR230","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1073\/pnas.1018064108","volume":"108","author":"SP Thankamony","year":"2011","unstructured":"Thankamony SP, Sackstein R (2011) Enforced hematopoietic cell E- and L-selectin ligand (HCELL) expression primes transendothelial migration of human mesenchymal stem cells. Proc Natl Acad Sci USA 108:2258\u20132263. https:\/\/doi.org\/10.1073\/pnas.1018064108","journal-title":"Proc Natl Acad Sci USA"},{"key":"3125_CR231","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1002\/stem.2614","volume":"35","author":"F Nitzsche","year":"2017","unstructured":"Nitzsche F et al (2017) Concise review: MSC adhesion cascade-insights into homing and transendothelial migration. Stem Cells 35:1446\u20131460. https:\/\/doi.org\/10.1002\/stem.2614","journal-title":"Stem Cells"},{"key":"3125_CR232","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1365-2141.2007.06610.x","volume":"137","author":"JM Fox","year":"2007","unstructured":"Fox JM, Chamberlain G, Ashton BA, Middleton J (2007) Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol 137:491\u2013502. https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06610.x","journal-title":"Br J Haematol"},{"key":"3125_CR233","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.cell.2008.01.041","volume":"132","author":"DJ Laird","year":"2008","unstructured":"Laird DJ, von Andrian UH, Wagers AJ (2008) Stem cell trafficking in tissue development, growth, and disease. Cell 132:612\u2013630. https:\/\/doi.org\/10.1016\/j.cell.2008.01.041","journal-title":"Cell"},{"key":"3125_CR234","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13287-015-0271-2","volume":"7","author":"J Leibacher","year":"2016","unstructured":"Leibacher J, Henschler R (2016) Biodistribution, migration and homing of systemically applied mesenchymal stem\/stromal cells. Stem Cell Res Ther 7:7. https:\/\/doi.org\/10.1186\/s13287-015-0271-2","journal-title":"Stem Cell Res Ther"},{"key":"3125_CR235","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/hep.25716","volume":"56","author":"V Aldridge","year":"2012","unstructured":"Aldridge V et al (2012) Human mesenchymal stem cells are recruited to injured liver in a beta1-integrin and CD44 dependent manner. Hepatology 56:1063\u20131073. https:\/\/doi.org\/10.1002\/hep.25716","journal-title":"Hepatology"},{"key":"3125_CR236","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1096\/fj.07-8275com","volume":"21","author":"S Kumar","year":"2007","unstructured":"Kumar S, Ponnazhagan S (2007) Bone homing of mesenchymal stem cells by ectopic alpha 4 integrin expression. FASEB J 21:3917\u20133927. https:\/\/doi.org\/10.1096\/fj.07-8275com","journal-title":"FASEB J"},{"key":"3125_CR237","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00441-010-0994-4","volume":"341","author":"JA Semon","year":"2010","unstructured":"Semon JA et al (2010) Integrin expression and integrin-mediated adhesion in vitro of human multipotent stromal cells (MSCs) to endothelial cells from various blood vessels. Cell Tissue Res 341:147\u2013158. https:\/\/doi.org\/10.1007\/s00441-010-0994-4","journal-title":"Cell Tissue Res"},{"key":"3125_CR238","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/jcb.21172","volume":"101","author":"J Ringe","year":"2007","unstructured":"Ringe J et al (2007) Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR238, CXCR238 and CCR238, and migrate upon stimulation with CXCL8 but not CCL2. J Cell Biochem 101:135\u2013146. https:\/\/doi.org\/10.1002\/jcb.21172","journal-title":"J Cell Biochem"},{"key":"3125_CR239","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1634\/stemcells.2007-0054","volume":"25","author":"AL Ponte","year":"2007","unstructured":"Ponte AL et al (2007) The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25:1737\u20131745. https:\/\/doi.org\/10.1634\/stemcells.2007-0054","journal-title":"Stem Cells"},{"key":"3125_CR240","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1182\/blood-2004-02-0526","volume":"104","author":"RF Wynn","year":"2004","unstructured":"Wynn RF et al (2004) A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR240 receptor capable of promoting migration to bone marrow. Blood 104:2643\u20132645. https:\/\/doi.org\/10.1182\/blood-2004-02-0526","journal-title":"Blood"},{"key":"3125_CR241","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s11033-013-2951-2","volume":"41","author":"R Ziaei","year":"2014","unstructured":"Ziaei R, Ayatollahi M, Yaghobi R, Sahraeian Z, Zarghami N (2014) Involvement of TNF-alpha in differential gene expression pattern of CXCR241 on human marrow-derived mesenchymal stem cells. Mol Biol Rep 41:1059\u20131066. https:\/\/doi.org\/10.1007\/s11033-013-2951-2","journal-title":"Mol Biol Rep"},{"key":"3125_CR242","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/cmi.2012.40","volume":"9","author":"H Fan","year":"2012","unstructured":"Fan H et al (2012) Pre-treatment with IL-1beta enhances the efficacy of MSC transplantation in DSS-induced colitis. Cell Mol Immunol 9:473\u2013481. https:\/\/doi.org\/10.1038\/cmi.2012.40","journal-title":"Cell Mol Immunol"},{"key":"3125_CR243","first-page":"97","volume":"38","author":"SA Park","year":"2011","unstructured":"Park SA et al (2011) CXCR243-transfected human umbilical cord blood-derived mesenchymal stem cells exhibit enhanced migratory capacity toward gliomas. Int J Oncol 38:97\u2013103","journal-title":"Int J Oncol"},{"key":"3125_CR244","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1182\/blood-2006-10-051060","volume":"109","author":"C Ries","year":"2007","unstructured":"Ries C et al (2007) MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 109:4055\u20134063. https:\/\/doi.org\/10.1182\/blood-2006-10-051060","journal-title":"Blood"},{"key":"3125_CR245","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/stem.50","volume":"27","author":"IA Ho","year":"2009","unstructured":"Ho IA et al (2009) Matrix metalloproteinase 1 is necessary for the migration of human bone marrow-derived mesenchymal stem cells toward human glioma. Stem Cells 27:1366\u20131375. https:\/\/doi.org\/10.1002\/stem.50","journal-title":"Stem Cells"},{"key":"3125_CR246","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1159\/000110447","volume":"20","author":"Y Kim","year":"2007","unstructured":"Kim Y et al (2007) Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia. Cell Physiol Biochem 20:867\u2013876. https:\/\/doi.org\/10.1159\/000110447","journal-title":"Cell Physiol Biochem"},{"key":"3125_CR247","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.nucmedbio.2011.03.008","volume":"38","author":"A Gholamrezanezhad","year":"2011","unstructured":"Gholamrezanezhad A et al (2011) In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis. Nucl Med Biol 38:961\u2013967. https:\/\/doi.org\/10.1016\/j.nucmedbio.2011.03.008","journal-title":"Nucl Med Biol"},{"key":"3125_CR248","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/scd.2008.0253","volume":"18","author":"UM Fischer","year":"2009","unstructured":"Fischer UM et al (2009) Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 18:683\u2013692. https:\/\/doi.org\/10.1089\/scd.2008.0253","journal-title":"Stem Cells Dev"},{"key":"3125_CR249","doi-asserted-by":"publisher","first-page":"40758","DOI":"10.1038\/srep40758","volume":"7","author":"B Argibay","year":"2017","unstructured":"Argibay B et al (2017) Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia. Sci Rep 7:40758. https:\/\/doi.org\/10.1038\/srep40758","journal-title":"Sci Rep"},{"key":"3125_CR250","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","volume":"99","author":"M Di Nicola","year":"2002","unstructured":"Di Nicola M et al (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838\u20133843","journal-title":"Blood"},{"key":"3125_CR251","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.4049\/jimmunol.1301828","volume":"192","author":"R Chinnadurai","year":"2014","unstructured":"Chinnadurai R, Copland IB, Patel SR, Galipeau J (2014) IDO-independent suppression of T cell effector function by IFN-gamma-licensed human mesenchymal stromal cells. J Immunol 192:1491\u20131501. https:\/\/doi.org\/10.4049\/jimmunol.1301828","journal-title":"J Immunol"},{"key":"3125_CR252","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1182\/blood-2004-09-3696","volume":"105","author":"S Glennie","year":"2005","unstructured":"Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F (2005) Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105:2821\u20132827. https:\/\/doi.org\/10.1182\/blood-2004-09-3696","journal-title":"Blood"},{"key":"3125_CR253","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1365-2249.2007.03422.x","volume":"149","author":"JM Ryan","year":"2007","unstructured":"Ryan JM, Barry F, Murphy JM, Mahon BP (2007) Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 149:353\u2013363. https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03422.x","journal-title":"Clin Exp Immunol"},{"key":"3125_CR254","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.ymthe.2017.12.013","volume":"26","author":"L Boland","year":"2018","unstructured":"Boland L et al (2018) IFN-gamma and TNF-alpha pre-licensing protects mesenchymal stromal cells from the pro-inflammatory effects of palmitate. Mol Ther 26:860\u2013873. https:\/\/doi.org\/10.1016\/j.ymthe.2017.12.013","journal-title":"Mol Ther"},{"key":"3125_CR255","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/leu.2011.108","volume":"25","author":"M Krampera","year":"2011","unstructured":"Krampera M (2011) Mesenchymal stromal cell \u2018licensing\u2019: a multistep process. Leukemia 25:1408\u20131414. https:\/\/doi.org\/10.1038\/leu.2011.108","journal-title":"Leukemia"},{"key":"3125_CR256","doi-asserted-by":"publisher","first-page":"e2062","DOI":"10.1038\/cddis.2015.327","volume":"7","author":"F Gao","year":"2016","unstructured":"Gao F et al (2016) Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis 7:e2062. https:\/\/doi.org\/10.1038\/cddis.2015.327","journal-title":"Cell Death Dis"},{"key":"3125_CR257","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","volume":"107","author":"A Corcione","year":"2006","unstructured":"Corcione A et al (2006) Human mesenchymal stem cells modulate B-cell functions. Blood 107:367\u2013372. https:\/\/doi.org\/10.1182\/blood-2005-07-2657","journal-title":"Blood"},{"key":"3125_CR258","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1634\/stemcells.2007-0554","volume":"26","author":"Z Selmani","year":"2008","unstructured":"Selmani Z et al (2008) Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+ CD25highFOXP3+ regulatory T cells. Stem Cells 26:212\u2013222. https:\/\/doi.org\/10.1634\/stemcells.2007-0554","journal-title":"Stem Cells"},{"key":"3125_CR259","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1182\/blood-2007-02-074997","volume":"111","author":"GM Spaggiari","year":"2008","unstructured":"Spaggiari GM et al (2008) Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111:1327\u20131333. https:\/\/doi.org\/10.1182\/blood-2007-02-074997","journal-title":"Blood"},{"key":"3125_CR260","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1182\/blood-2004-02-0586","volume":"105","author":"XX Jiang","year":"2005","unstructured":"Jiang XX et al (2005) Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105:4120\u20134126. https:\/\/doi.org\/10.1182\/blood-2004-02-0586","journal-title":"Blood"},{"key":"3125_CR261","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/01.tp.0000244572.24780.54","volume":"83","author":"R Ramasamy","year":"2007","unstructured":"Ramasamy R et al (2007) Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 83:71\u201376. https:\/\/doi.org\/10.1097\/01.tp.0000244572.24780.54","journal-title":"Transplantation"},{"key":"3125_CR262","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/stem.1191","volume":"30","author":"JH Ylostalo","year":"2012","unstructured":"Ylostalo JH, Bartosh TJ, Coble K, Prockop DJ (2012) Human mesenchymal stem\/stromal cells cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype. Stem Cells 30:2283\u20132296. https:\/\/doi.org\/10.1002\/stem.1191","journal-title":"Stem Cells"},{"key":"3125_CR263","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4049\/jimmunol.0902007","volume":"185","author":"S Ghannam","year":"2010","unstructured":"Ghannam S, Pene J, Moquet-Torcy G, Jorgensen C, Yssel H (2010) Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. J Immunol 185:302\u2013312. https:\/\/doi.org\/10.4049\/jimmunol.0902007","journal-title":"J Immunol"},{"key":"3125_CR264","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.5966\/sctm.2015-0243","volume":"5","author":"A Rozenberg","year":"2016","unstructured":"Rozenberg A et al (2016) Human mesenchymal stem cells impact Th17 and Th1 responses through a prostaglandin E2 and myeloid-dependent mechanism. Stem Cells Transl Med 5:1506\u20131514. https:\/\/doi.org\/10.5966\/sctm.2015-0243","journal-title":"Stem Cells Transl Med"},{"key":"3125_CR265","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/glia.20841","volume":"57","author":"L Bai","year":"2009","unstructured":"Bai L et al (2009) Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 57:1192\u20131203. https:\/\/doi.org\/10.1002\/glia.20841","journal-title":"Glia"},{"key":"3125_CR266","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.4049\/jimmunol.177.4.2080","volume":"177","author":"AJ Nauta","year":"2006","unstructured":"Nauta AJ, Kruisselbrink AB, Lurvink E, Willemze R, Fibbe WE (2006) Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J Immunol 177:2080\u20132087","journal-title":"J Immunol"},{"key":"3125_CR267","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/scrt216","volume":"4","author":"P Luz-Crawford","year":"2013","unstructured":"Luz-Crawford P et al (2013) Mesenchymal stem cells generate a CD4+ CD25+ Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Res Ther 4:65. https:\/\/doi.org\/10.1186\/scrt216","journal-title":"Stem Cell Res Ther"},{"key":"3125_CR268","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/cmi.2014.118","volume":"12","author":"Q Liu","year":"2015","unstructured":"Liu Q et al (2015) Human mesenchymal stromal cells enhance the immunomodulatory function of CD8(+)CD28(\u2212) regulatory T cells. Cell Mol Immunol 12:708\u2013718. https:\/\/doi.org\/10.1038\/cmi.2014.118","journal-title":"Cell Mol Immunol"},{"key":"3125_CR269","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/cmi.2016.59","volume":"14","author":"KA Cho","year":"2017","unstructured":"Cho KA et al (2017) Mesenchymal stem cells ameliorate B-cell-mediated immune responses and increase IL-10-expressing regulatory B cells in an EBI3-dependent manner. Cell Mol Immunol 14:895. https:\/\/doi.org\/10.1038\/cmi.2016.59","journal-title":"Cell Mol Immunol"},{"key":"3125_CR270","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.4049\/jimmunol.1102996","volume":"189","author":"X Liu","year":"2012","unstructured":"Liu X et al (2012) Mesenchymal stem\/stromal cells induce the generation of novel IL-10-dependent regulatory dendritic cells by SOCS3 activation. J Immunol 189:1182\u20131192. https:\/\/doi.org\/10.4049\/jimmunol.1102996","journal-title":"J Immunol"},{"key":"3125_CR271","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.exphem.2009.09.004","volume":"37","author":"J Kim","year":"2009","unstructured":"Kim J, Hematti P (2009) Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol 37:1445\u20131453. https:\/\/doi.org\/10.1016\/j.exphem.2009.09.004","journal-title":"Exp Hematol"},{"key":"3125_CR272","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726\u2013736. https:\/\/doi.org\/10.1038\/nri2395","journal-title":"Nat Rev Immunol"},{"key":"3125_CR273","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.bbmt.2005.01.005","volume":"11","author":"K Le Blanc","year":"2005","unstructured":"Le Blanc K, Ringden O (2005) Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11:321\u2013334. https:\/\/doi.org\/10.1016\/j.bbmt.2005.01.005","journal-title":"Biol Blood Marrow Transplant"},{"key":"3125_CR274","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","volume":"110","author":"AJ Nauta","year":"2007","unstructured":"Nauta AJ, Fibbe WE (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499\u20133506. https:\/\/doi.org\/10.1182\/blood-2007-02-069716","journal-title":"Blood"},{"key":"3125_CR275","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","volume":"371","author":"K Le Blanc","year":"2008","unstructured":"Le Blanc K et al (2008) Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371:1579\u20131586. https:\/\/doi.org\/10.1016\/S0140-6736(08)60690-X","journal-title":"Lancet"},{"key":"3125_CR276","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","volume":"363","author":"K Le Blanc","year":"2004","unstructured":"Le Blanc K et al (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439\u20131441. https:\/\/doi.org\/10.1016\/S0140-6736(04)16104-7","journal-title":"Lancet"},{"key":"3125_CR277","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1001\/jama.2012.316","volume":"307","author":"J Tan","year":"2012","unstructured":"Tan J et al (2012) Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA 307:1169\u20131177. https:\/\/doi.org\/10.1001\/jama.2012.316","journal-title":"JAMA"},{"key":"3125_CR278","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/TP.0b013e3182754c53","volume":"95","author":"Y Peng","year":"2013","unstructured":"Peng Y et al (2013) Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study. Transplantation 95:161\u2013168. https:\/\/doi.org\/10.1097\/TP.0b013e3182754c53","journal-title":"Transplantation"},{"key":"3125_CR279","doi-asserted-by":"publisher","first-page":"2352954","DOI":"10.1155\/2017\/2352954","volume":"2017","author":"S Hartleif","year":"2017","unstructured":"Hartleif S et al (2017) Safety and tolerance of donor-derived mesenchymal stem cells in pediatric living-donor liver transplantation: the MYSTEP1 study. Stem Cells Int 2017:2352954. https:\/\/doi.org\/10.1155\/2017\/2352954","journal-title":"Stem Cells Int"},{"key":"3125_CR280","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2215\/CJN.04950610","volume":"6","author":"N Perico","year":"2011","unstructured":"Perico N et al (2011) Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. Clin J Am Soc Nephrol 6:412\u2013422. https:\/\/doi.org\/10.2215\/CJN.04950610","journal-title":"Clin J Am Soc Nephrol"},{"key":"3125_CR281","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5966\/sctm.2012-0114","volume":"2","author":"ME Reinders","year":"2013","unstructured":"Reinders ME et al (2013) Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Transl Med 2:107\u2013111. https:\/\/doi.org\/10.5966\/sctm.2012-0114","journal-title":"Stem Cells Transl Med"},{"key":"3125_CR282","doi-asserted-by":"publisher","first-page":"12089","DOI":"10.18632\/oncotarget.7725","volume":"7","author":"GH Pan","year":"2016","unstructured":"Pan GH et al (2016) Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study. Oncotarget 7:12089\u201312101. https:\/\/doi.org\/10.18632\/oncotarget.7725","journal-title":"Oncotarget"},{"key":"3125_CR283","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jhep.2017.03.001","volume":"67","author":"O Detry","year":"2017","unstructured":"Detry O et al (2017) Infusion of mesenchymal stromal cells after deceased liver transplantation: a phase I\u2013II, open-label, clinical study. J Hepatol 67:47\u201355. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.001","journal-title":"J Hepatol"},{"key":"3125_CR284","doi-asserted-by":"publisher","first-page":"899","DOI":"10.5966\/sctm.2015-0002","volume":"4","author":"Y Soeder","year":"2015","unstructured":"Soeder Y et al (2015) First-in-human case study: multipotent adult progenitor cells for immunomodulation after liver transplantation. Stem Cells Transl Med 4:899\u2013904. https:\/\/doi.org\/10.5966\/sctm.2015-0002","journal-title":"Stem Cells Transl Med"},{"key":"3125_CR285","doi-asserted-by":"publisher","first-page":"38008","DOI":"10.18632\/oncotarget.16682","volume":"8","author":"F Mao","year":"2017","unstructured":"Mao F et al (2017) Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease. Oncotarget 8:38008\u201338021. https:\/\/doi.org\/10.18632\/oncotarget.16682","journal-title":"Oncotarget"},{"key":"3125_CR286","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1136\/gut.2010.215152","volume":"59","author":"M Duijvestein","year":"2010","unstructured":"Duijvestein M et al (2010) Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn\u2019s disease: results of a phase I study. Gut 59:1662\u20131669. https:\/\/doi.org\/10.1136\/gut.2010.215152","journal-title":"Gut"},{"key":"3125_CR287","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1136\/gut.2010.214841","volume":"60","author":"R Ciccocioppo","year":"2011","unstructured":"Ciccocioppo R et al (2011) Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn\u2019s disease. Gut 60:788\u2013798. https:\/\/doi.org\/10.1136\/gut.2010.214841","journal-title":"Gut"},{"key":"3125_CR288","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cgh.2013.06.021","volume":"12","author":"GM Forbes","year":"2014","unstructured":"Forbes GM et al (2014) A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn\u2019s disease refractory to biologic therapy. Clin Gastroenterol Hepatol 12:64\u201371. https:\/\/doi.org\/10.1016\/j.cgh.2013.06.021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3125_CR289","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/annrheumdis-2015-208918","volume":"76","author":"JM Alvaro-Gracia","year":"2017","unstructured":"Alvaro-Gracia JM et al (2017) Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib\/IIa clinical trial. Ann Rheum Dis 76:196\u2013202. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208918","journal-title":"Ann Rheum Dis"},{"key":"3125_CR290","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrrheum.2009.104","volume":"5","author":"F Djouad","year":"2009","unstructured":"Djouad F, Bouffi C, Ghannam S, Noel D, Jorgensen C (2009) Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases. Nat Rev Rheumatol 5:392\u2013399. https:\/\/doi.org\/10.1038\/nrrheum.2009.104","journal-title":"Nat Rev Rheumatol"},{"key":"3125_CR291","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/ard.2008.101881","volume":"69","author":"E Gonzalez-Rey","year":"2010","unstructured":"Gonzalez-Rey E et al (2010) Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis 69:241\u2013248. https:\/\/doi.org\/10.1136\/ard.2008.101881","journal-title":"Ann Rheum Dis"},{"key":"3125_CR292","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2017.12.020","volume":"154","author":"J Panes","year":"2018","unstructured":"Panes J et al (2018) Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn\u2019s disease. Gastroenterology 154:1334\u20131342 e1334. https:\/\/doi.org\/10.1053\/j.gastro.2017.12.020","journal-title":"Gastroenterology"},{"key":"3125_CR293","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.stemcr.2018.01.029","volume":"10","author":"D Wang","year":"2018","unstructured":"Wang D et al (2018) A long-term follow-up study of allogeneic mesenchymal stem\/stromal cell transplantation in patients with drug-resistant systemic lupus erythematosus. Stem Cell Rep 10:933\u2013941. https:\/\/doi.org\/10.1016\/j.stemcr.2018.01.029","journal-title":"Stem Cell Rep"},{"key":"3125_CR294","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1002\/stem.708","volume":"29","author":"GW Roddy","year":"2011","unstructured":"Roddy GW et al (2011) Action at a distance: systemically administered adult stem\/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-alpha stimulated gene\/protein 6. Stem Cells 29:1572\u20131579. https:\/\/doi.org\/10.1002\/stem.708","journal-title":"Stem Cells"},{"key":"3125_CR295","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4252\/wjsc.v8.i3.73","volume":"8","author":"A De Becker","year":"2016","unstructured":"De Becker A, Riet IV (2016) Homing and migration of mesenchymal stromal cells: how to improve the efficacy of cell therapy? World J Stem Cells 8:73\u201387. https:\/\/doi.org\/10.4252\/wjsc.v8.i3.73","journal-title":"World J Stem Cells"},{"key":"3125_CR296","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2121-11-29","volume":"11","author":"A Cselenyak","year":"2010","unstructured":"Cselenyak A, Pankotai E, Horvath EM, Kiss L, Lacza Z (2010) Mesenchymal stem cells rescue cardiomyoblasts from cell death in an in vitro ischemia model via direct cell-to-cell connections. BMC Cell Biol 11:29. https:\/\/doi.org\/10.1186\/1471-2121-11-29","journal-title":"BMC Cell Biol"},{"key":"3125_CR297","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10571-016-0370-3","volume":"37","author":"D Kong","year":"2017","unstructured":"Kong D et al (2017) Mesenchymal stem cells protect neurons against hypoxic-ischemic injury via inhibiting parthanatos, necroptosis, and apoptosis, but not autophagy. Cell Mol Neurobiol 37:303\u2013313. https:\/\/doi.org\/10.1007\/s10571-016-0370-3","journal-title":"Cell Mol Neurobiol"},{"key":"3125_CR298","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/cdd.2017.51","volume":"24","author":"M Mahrouf-Yorgov","year":"2017","unstructured":"Mahrouf-Yorgov M et al (2017) Mesenchymal stem cells sense mitochondria released from damaged cells as danger signals to activate their rescue properties. Cell Death Differ 24:1224\u20131238. https:\/\/doi.org\/10.1038\/cdd.2017.51","journal-title":"Cell Death Differ"},{"key":"3125_CR299","doi-asserted-by":"publisher","first-page":"26162","DOI":"10.1038\/srep26162","volume":"6","author":"A Naji","year":"2016","unstructured":"Naji A et al (2016) Endocytosis of indium-tin-oxide nanoparticles by macrophages provokes pyroptosis requiring NLRP3-ASC-Caspase1 axis that can be prevented by mesenchymal stem cells. Sci Rep 6:26162. https:\/\/doi.org\/10.1038\/srep26162","journal-title":"Sci Rep"},{"key":"3125_CR300","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10571-012-9798-2","volume":"32","author":"F Scheibe","year":"2012","unstructured":"Scheibe F, Klein O, Klose J, Priller J (2012) Mesenchymal stromal cells rescue cortical neurons from apoptotic cell death in an in vitro model of cerebral ischemia. Cell Mol Neurobiol 32:567\u2013576. https:\/\/doi.org\/10.1007\/s10571-012-9798-2","journal-title":"Cell Mol Neurobiol"},{"key":"3125_CR301","doi-asserted-by":"publisher","first-page":"e1885","DOI":"10.1038\/cddis.2015.230","volume":"6","author":"K Zhao","year":"2015","unstructured":"Zhao K et al (2015) Bone marrow-derived mesenchymal stem cells ameliorate chronic high glucose-induced beta-cell injury through modulation of autophagy. Cell Death Dis 6:e1885. https:\/\/doi.org\/10.1038\/cddis.2015.230","journal-title":"Cell Death Dis"},{"key":"3125_CR302","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.neuroscience.2011.06.088","volume":"193","author":"N Zilka","year":"2011","unstructured":"Zilka N et al (2011) Mesenchymal stem cells rescue the Alzheimer\u2019s disease cell model from cell death induced by misfolded truncated tau. Neuroscience 193:330\u2013337. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.06.088","journal-title":"Neuroscience"},{"key":"3125_CR303","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1126\/science.1107627","volume":"308","author":"I Kratchmarova","year":"2005","unstructured":"Kratchmarova I, Blagoev B, Haack-Sorensen M, Kassem M, Mann M (2005) Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 308:1472\u20131477. https:\/\/doi.org\/10.1126\/science.1107627","journal-title":"Science"},{"key":"3125_CR304","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/jcp.21854","volume":"221","author":"MO Platt","year":"2009","unstructured":"Platt MO, Roman AJ, Wells A, Lauffenburger DA, Griffith LG (2009) Sustained epidermal growth factor receptor levels and activation by tethered ligand binding enhances osteogenic differentiation of multi-potent marrow stromal cells. J Cell Physiol 221:306\u2013317. https:\/\/doi.org\/10.1002\/jcp.21854","journal-title":"J Cell Physiol"},{"key":"3125_CR305","doi-asserted-by":"publisher","first-page":"4897","DOI":"10.1074\/jbc.M805432200","volume":"284","author":"H Miraoui","year":"2009","unstructured":"Miraoui H et al (2009) Fibroblast growth factor receptor 2 promotes osteogenic differentiation in mesenchymal cells via ERK1\/2 and protein kinase C signaling. J Biol Chem 284:4897\u20134904. https:\/\/doi.org\/10.1074\/jbc.M805432200","journal-title":"J Biol Chem"},{"key":"3125_CR306","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1210\/jc.2003-031682","volume":"89","author":"LM Scavo","year":"2004","unstructured":"Scavo LM, Karas M, Murray M, Leroith D (2004) Insulin-like growth factor-I stimulates both cell growth and lipogenesis during differentiation of human mesenchymal stem cells into adipocytes. J Clin Endocrinol Metab 89:3543\u20133553. https:\/\/doi.org\/10.1210\/jc.2003-031682","journal-title":"J Clin Endocrinol Metab"},{"key":"3125_CR307","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/s00776-003-0702-2","volume":"8","author":"BA Roelen","year":"2003","unstructured":"Roelen BA, Dijke P (2003) Controlling mesenchymal stem cell differentiation by TGFBeta family members. J Orthop Sci 8:740\u2013748. https:\/\/doi.org\/10.1007\/s00776-003-0702-2","journal-title":"J Orthop Sci"},{"key":"3125_CR308","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/sj.emboj.7600067","volume":"23","author":"S Maeda","year":"2004","unstructured":"Maeda S, Hayashi M, Komiya S, Imamura T, Miyazono K (2004) Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells. EMBO J 23:552\u2013563. https:\/\/doi.org\/10.1038\/sj.emboj.7600067","journal-title":"EMBO J"},{"key":"3125_CR309","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/jcb.23345","volume":"113","author":"FS Oliveira","year":"2012","unstructured":"Oliveira FS et al (2012) Hedgehog signaling and osteoblast gene expression are regulated by purmorphamine in human mesenchymal stem cells. J Cell Biochem 113:204\u2013208. https:\/\/doi.org\/10.1002\/jcb.23345","journal-title":"J Cell Biochem"},{"key":"3125_CR310","doi-asserted-by":"publisher","first-page":"30938","DOI":"10.1074\/jbc.M702391200","volume":"282","author":"J Chang","year":"2007","unstructured":"Chang J et al (2007) Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK. J Biol Chem 282:30938\u201330948. https:\/\/doi.org\/10.1074\/jbc.M702391200","journal-title":"J Biol Chem"},{"key":"3125_CR311","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.exphem.2009.03.007","volume":"37","author":"F Ugarte","year":"2009","unstructured":"Ugarte F et al (2009) Notch signaling enhances osteogenic differentiation while inhibiting adipogenesis in primary human bone marrow stromal cells. Exp Hematol 37:867\u2013875 e861. https:\/\/doi.org\/10.1016\/j.exphem.2009.03.007","journal-title":"Exp Hematol"},{"key":"3125_CR312","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/jcb.23079","volume":"112","author":"S Zhou","year":"2011","unstructured":"Zhou S (2011) TGF-beta regulates beta-catenin signaling and osteoblast differentiation in human mesenchymal stem cells. J Cell Biochem 112:1651\u20131660. https:\/\/doi.org\/10.1002\/jcb.23079","journal-title":"J Cell Biochem"},{"key":"3125_CR313","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1471-213X-10-47","volume":"10","author":"SW Qian","year":"2010","unstructured":"Qian SW et al (2010) Characterization of adipocyte differentiation from human mesenchymal stem cells in bone marrow. BMC Dev Biol 10:47. https:\/\/doi.org\/10.1186\/1471-213X-10-47","journal-title":"BMC Dev Biol"},{"key":"3125_CR314","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1002\/sctm.17-0137","volume":"6","author":"L Thiagarajan","year":"2017","unstructured":"Thiagarajan L, Abu-Awwad HAM, Dixon JE (2017) Osteogenic programming of human mesenchymal stem cells with highly efficient intracellular delivery of RUNX2. Stem Cells Transl Med 6:2146\u20132159. https:\/\/doi.org\/10.1002\/sctm.17-0137","journal-title":"Stem Cells Transl Med"},{"key":"3125_CR315","first-page":"2527","volume":"7","author":"J Xu","year":"2015","unstructured":"Xu J, Li Z, Hou Y, Fang W (2015) Potential mechanisms underlying the Runx2 induced osteogenesis of bone marrow mesenchymal stem cells. Am J Transl Res 7:2527\u20132535","journal-title":"Am J Transl Res"},{"key":"3125_CR316","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.biocel.2011.11.013","volume":"44","author":"WH Yu","year":"2012","unstructured":"Yu WH et al (2012) PPARgamma suppression inhibits adipogenesis but does not promote osteogenesis of human mesenchymal stem cells. Int J Biochem Cell Biol 44:377\u2013384. https:\/\/doi.org\/10.1016\/j.biocel.2011.11.013","journal-title":"Int J Biochem Cell Biol"},{"key":"3125_CR317","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/jcp.23010","volume":"227","author":"F Zhu","year":"2012","unstructured":"Zhu F, Friedman MS, Luo W, Woolf P, Hankenson KD (2012) The transcription factor osterix (SP7) regulates BMP6-induced human osteoblast differentiation. J Cell Physiol 227:2677\u20132685. https:\/\/doi.org\/10.1002\/jcp.23010","journal-title":"J Cell Physiol"},{"key":"3125_CR318","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/scrt412","volume":"5","author":"TO Pedersen","year":"2014","unstructured":"Pedersen TO et al (2014) Mesenchymal stem cells induce endothelial cell quiescence and promote capillary formation. Stem Cell Res Ther 5:23. https:\/\/doi.org\/10.1186\/scrt412","journal-title":"Stem Cell Res Ther"},{"key":"3125_CR319","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1089\/scd.2013.0396","volume":"23","author":"PJ Kingham","year":"2014","unstructured":"Kingham PJ, Kolar MK, Novikova LN, Novikov LN, Wiberg M (2014) Stimulating the neurotrophic and angiogenic properties of human adipose-derived stem cells enhances nerve repair. Stem Cells Dev 23:741\u2013754. https:\/\/doi.org\/10.1089\/scd.2013.0396","journal-title":"Stem Cells Dev"},{"key":"3125_CR320","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/scrt314","volume":"4","author":"D Li","year":"2013","unstructured":"Li D et al (2013) Mesenchymal stem cells protect podocytes from apoptosis induced by high glucose via secretion of epithelial growth factor. Stem Cell Res Ther 4:103. https:\/\/doi.org\/10.1186\/scrt314","journal-title":"Stem Cell Res Ther"},{"key":"3125_CR321","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13287-018-0781-9","volume":"9","author":"C Ding","year":"2018","unstructured":"Ding C et al (2018) Human amniotic mesenchymal stem cells improve ovarian function in natural aging through secreting hepatocyte growth factor and epidermal growth factor. Stem Cell Res Ther 9:55. https:\/\/doi.org\/10.1186\/s13287-018-0781-9","journal-title":"Stem Cell Res Ther"},{"key":"3125_CR322","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.exphem.2007.01.044","volume":"35","author":"KJ Zwezdaryk","year":"2007","unstructured":"Zwezdaryk KJ et al (2007) Erythropoietin, a hypoxia-regulated factor, elicits a pro-angiogenic program in human mesenchymal stem cells. Exp Hematol 35:640\u2013652","journal-title":"Exp Hematol"},{"key":"3125_CR323","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jtcvs.2007.07.071","volume":"135","author":"X Hu","year":"2008","unstructured":"Hu X et al (2008) Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg 135:799\u2013808","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3125_CR324","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1089\/scd.2013.0118","volume":"22","author":"L Wu","year":"2013","unstructured":"Wu L, Leijten J, van Blitterswijk CA, Karperien M (2013) Fibroblast growth factor-1 is a mesenchymal stromal cell-secreted factor stimulating proliferation of osteoarthritic chondrocytes in co-culture. Stem Cells Dev 22:2356\u20132367. https:\/\/doi.org\/10.1089\/scd.2013.0118","journal-title":"Stem Cells Dev"},{"key":"3125_CR325","doi-asserted-by":"publisher","first-page":"125643","DOI":"10.1155\/2014\/125683","volume":"2014","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Wang Y, Li M, Li J, Wu J (2014) Fibroblast growth factor 18 increases the trophic effects of bone marrow mesenchymal stem cells on chondrocytes isolated from late stage osteoarthritic patients. Stem Cells Int 2014:125643. https:\/\/doi.org\/10.1155\/2014\/125683","journal-title":"Stem Cells Int"},{"key":"3125_CR326","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/jnr.21056","volume":"84","author":"Y Horita","year":"2006","unstructured":"Horita Y et al (2006) Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J Neurosci Res 84:1495\u20131504","journal-title":"J Neurosci Res"},{"key":"3125_CR327","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.nbd.2007.06.010","volume":"27","author":"D-C Ding","year":"2007","unstructured":"Ding D-C et al (2007) Enhancement of neuroplasticity through upregulation of \u03b21-integrin in human umbilical cord-derived stromal cell implanted stroke model. Neurobiol Dis 27:339\u2013353","journal-title":"Neurobiol Dis"},{"key":"3125_CR328","doi-asserted-by":"publisher","first-page":"129145","DOI":"10.1155\/2014\/129145","volume":"2014","author":"CH Jeong","year":"2014","unstructured":"Jeong CH et al (2014) Mesenchymal stem cells expressing brain-derived neurotrophic factor enhance endogenous neurogenesis in an ischemic stroke model. Biomed Res Int 2014:129145. https:\/\/doi.org\/10.1155\/2014\/129145","journal-title":"Biomed Res Int"},{"key":"3125_CR329","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1634\/stemcells.22-3-405","volume":"22","author":"S Neuss","year":"2004","unstructured":"Neuss S, Becher E, Woltje M, Tietze L, Jahnen-Dechent W (2004) Functional expression of HGF and HGF receptor\/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Stem Cells 22:405\u2013414. https:\/\/doi.org\/10.1634\/stemcells.22-3-405","journal-title":"Stem Cells"},{"key":"3125_CR330","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.brainres.2004.09.061","volume":"1030","author":"J Zhang","year":"2004","unstructured":"Zhang J et al (2004) Expression of insulin-like growth factor 1 and receptor in ischemic rats treated with human marrow stromal cells. Brain Res 1030:19\u201327","journal-title":"Brain Res"},{"key":"3125_CR331","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/mp.2009.110","volume":"15","author":"M Tfilin","year":"2010","unstructured":"Tfilin M et al (2010) Mesenchymal stem cells increase hippocampal neurogenesis and counteract depressive-like behavior. Mol Psychiatry 15:1164\u20131175. https:\/\/doi.org\/10.1038\/mp.2009.110","journal-title":"Mol Psychiatry"},{"key":"3125_CR332","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1210\/jcem.82.10.4294","volume":"82","author":"ML Casey","year":"1997","unstructured":"Casey ML, MacDonald PC (1997) Keratinocyte growth factor expression in the mesenchymal cells of human amnion. J Clin Endocrinol Metab 82:3319\u20133323. https:\/\/doi.org\/10.1210\/jcem.82.10.4294","journal-title":"J Clin Endocrinol Metab"},{"key":"3125_CR333","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/stem.1504","volume":"32","author":"YG Zhu","year":"2014","unstructured":"Zhu YG et al (2014) Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem cells 32:116\u2013125","journal-title":"Stem cells"},{"key":"3125_CR334","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1182\/blood-2010-02-269894","volume":"116","author":"W Ding","year":"2010","unstructured":"Ding W et al (2010) Platelet-derived growth factor (PDGF)\u2013PDGF receptor interaction activates bone marrow\u2013derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch. Blood 116:2984\u20132993","journal-title":"Blood"},{"key":"3125_CR335","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/stem.2722","volume":"36","author":"A Osborne","year":"2018","unstructured":"Osborne A, Sanderson J, Martin KR (2018) Neuroprotective effects of human mesenchymal stem cells and platelet-derived growth factor on human retinal ganglion cells. Stem Cells 36:65\u201378","journal-title":"Stem Cells"},{"key":"3125_CR336","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1158\/0008-5472.CAN-08-0943","volume":"68","author":"PJ Mishra","year":"2008","unstructured":"Mishra PJ et al (2008) Carcinoma-associated fibroblast\u2013like differentiation of human mesenchymal stem cells. Can Res 68:4331\u20134339","journal-title":"Can Res"},{"key":"3125_CR337","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/jcb.20462","volume":"95","author":"H Mayer","year":"2005","unstructured":"Mayer H et al (2005) Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem 95:827\u2013839. https:\/\/doi.org\/10.1002\/jcb.20462","journal-title":"J Cell Biochem"},{"key":"3125_CR338","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/sj.bjc.6604508","volume":"99","author":"BM Beckermann","year":"2008","unstructured":"Beckermann BM et al (2008) VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer 99:622\u2013631. https:\/\/doi.org\/10.1038\/sj.bjc.6604508","journal-title":"Br J Cancer"},{"key":"3125_CR339","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/sj.ki.5002334","volume":"72","author":"MB Herrera","year":"2007","unstructured":"Herrera MB et al (2007) Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int 72:430\u2013441. https:\/\/doi.org\/10.1038\/sj.ki.5002334","journal-title":"Kidney Int"},{"key":"3125_CR340","doi-asserted-by":"publisher","first-page":"e186","DOI":"10.1038\/cddis.2011.71","volume":"2","author":"C Popov","year":"2011","unstructured":"Popov C et al (2011) Integrins alpha2beta1 and alpha11beta1 regulate the survival of mesenchymal stem cells on collagen I. Cell Death Dis 2:e186. https:\/\/doi.org\/10.1038\/cddis.2011.71","journal-title":"Cell Death Dis"},{"key":"3125_CR341","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1089\/scd.2011.0615","volume":"21","author":"JE Frith","year":"2012","unstructured":"Frith JE, Mills RJ, Hudson JE, Cooper-White JJ (2012) Tailored integrin\u2013extracellular matrix interactions to direct human mesenchymal stem cell differentiation. Stem Cells Dev 21:2442\u20132456","journal-title":"Stem Cells Dev"},{"key":"3125_CR342","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1242\/jcs.076935","volume":"124","author":"J Veevers-Lowe","year":"2011","unstructured":"Veevers-Lowe J, Ball SG, Shuttleworth A, Kielty CM (2011) Mesenchymal stem cell migration is regulated by fibronectin through \u03b15\u03b21-integrin-mediated activation of PDGFR-\u03b2 and potentiation of growth factor signals. J Cell Sci 124:1288\u20131300","journal-title":"J Cell Sci"},{"key":"3125_CR343","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1089\/scd.2005.14.329","volume":"14","author":"IV L\u00fcttichau","year":"2005","unstructured":"L\u00fcttichau IV et al (2005) Human adult CD34\u2212 progenitor cells functionally express the chemokine receptors CCR344, CCR344, CCR344, CXCR344, and CCR344 but not CXCR344. Stem cells and development 14:329\u2013336","journal-title":"Stem cells and development"},{"key":"3125_CR344","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3858\/emm.2011.43.10.069","volume":"43","author":"SJ Baek","year":"2011","unstructured":"Baek SJ, Kang SK, Ra JC (2011) In vitro migration capacity of human adipose tissue-derived mesenchymal stem cells reflects their expression of receptors for chemokines and growth factors. Exp Mol Med 43:596","journal-title":"Exp Mol Med"},{"key":"3125_CR345","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1038\/ncomms2766","volume":"4","author":"Y Jung","year":"2013","unstructured":"Jung Y et al (2013) Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis. Nat Commun 4:1795","journal-title":"Nat Commun"},{"key":"3125_CR346","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1182\/blood-2009-06-228494","volume":"115","author":"C Lu","year":"2010","unstructured":"Lu C, Li X-Y, Hu Y, Rowe RG, Weiss SJ (2010) MT1-MMP controls human mesenchymal stem cell trafficking and differentiation. Blood 115:221\u2013229","journal-title":"Blood"},{"key":"3125_CR347","doi-asserted-by":"publisher","first-page":"E309","DOI":"10.1073\/pnas.1115083109","volume":"109","author":"V Egea","year":"2012","unstructured":"Egea V et al (2012) Tissue inhibitor of metalloproteinase-1 (TIMP-1) regulates mesenchymal stem cells through let-7f microRNA and Wnt\/\u03b2-catenin signaling. Proc Natl Acad Sci 109:E309\u2013E316","journal-title":"Proc Natl Acad Sci"},{"key":"3125_CR348","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1159\/000485533","volume":"44","author":"B Chelluboina","year":"2017","unstructured":"Chelluboina B et al (2017) Mesenchymal stem cell treatment prevents post-stroke dysregulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases. Cell Physiol Biochem 44:1360\u20131369","journal-title":"Cell Physiol Biochem"},{"key":"3125_CR349","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1080\/14653240903079377","volume":"11","author":"M Najar","year":"2009","unstructured":"Najar M et al (2009) Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6. Cytotherapy 11:570\u2013583. https:\/\/doi.org\/10.1080\/14653240903079377","journal-title":"Cytotherapy"},{"key":"3125_CR350","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1182\/blood-2004-07-2921","volume":"105","author":"S Beyth","year":"2005","unstructured":"Beyth S et al (2005) Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105:2214\u20132219. https:\/\/doi.org\/10.1182\/blood-2004-07-2921","journal-title":"Blood"},{"key":"3125_CR351","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.yexcr.2004.12.013","volume":"305","author":"I Rasmusson","year":"2005","unstructured":"Rasmusson I, Ringden O, Sundberg B, Le Blanc K (2005) Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 305:33\u201341. https:\/\/doi.org\/10.1016\/j.yexcr.2004.12.013","journal-title":"Exp Cell Res"},{"key":"3125_CR352","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cellimm.2008.06.002","volume":"253","author":"A Nasef","year":"2008","unstructured":"Nasef A et al (2008) Leukemia inhibitory factor: role in human mesenchymal stem cells mediated immunosuppression. Cell Immunol 253:16\u201322. https:\/\/doi.org\/10.1016\/j.cellimm.2008.06.002","journal-title":"Cell Immunol"},{"key":"3125_CR353","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1634\/stemcells.2004-0359","volume":"24","author":"PA Sotiropoulou","year":"2006","unstructured":"Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M (2006) Interactions between human mesenchymal stem cells and natural killer cells. Stem cells 24:74\u201385","journal-title":"Stem cells"},{"key":"3125_CR354","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.4049\/jimmunol.0903143","volume":"184","author":"SA Patel","year":"2010","unstructured":"Patel SA et al (2010) Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-\u03b2. J Immunol 184:5885\u20135894","journal-title":"J Immunol"},{"key":"3125_CR355","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1182\/blood-2010-12-327353","volume":"118","author":"H Choi","year":"2011","unstructured":"Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ (2011) Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2\/NF-kappaB signaling in resident macrophages. Blood 118:330\u2013338. https:\/\/doi.org\/10.1182\/blood-2010-12-327353","journal-title":"Blood"},{"key":"3125_CR356","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1182\/blood-2010-12-324038","volume":"117","author":"D Mougiakakos","year":"2011","unstructured":"Mougiakakos D et al (2011) The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood 117:4826\u20134835. https:\/\/doi.org\/10.1182\/blood-2010-12-324038","journal-title":"Blood"},{"key":"3125_CR357","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/mt.2011.189","volume":"20","author":"M Francois","year":"2012","unstructured":"Francois M, Romieu-Mourez R, Li M, Galipeau J (2012) Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther 20:187\u2013195. https:\/\/doi.org\/10.1038\/mt.2011.189","journal-title":"Mol Ther"},{"key":"3125_CR358","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1002\/stem.118","volume":"27","author":"G Ren","year":"2009","unstructured":"Ren G et al (2009) Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 27:1954\u20131962. https:\/\/doi.org\/10.1002\/stem.118","journal-title":"Stem Cells"},{"key":"3125_CR359","doi-asserted-by":"publisher","first-page":"6576","DOI":"10.1182\/blood-2009-02-203943","volume":"113","author":"GM Spaggiari","year":"2009","unstructured":"Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L (2009) MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113:6576\u20136583. https:\/\/doi.org\/10.1182\/blood-2009-02-203943","journal-title":"Blood"},{"key":"3125_CR360","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1182\/blood-2010-02-270777","volume":"116","author":"F Gieseke","year":"2010","unstructured":"Gieseke F et al (2010) Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Blood 116:3770\u20133779. https:\/\/doi.org\/10.1182\/blood-2010-02-270777","journal-title":"Blood"},{"key":"3125_CR361","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1089\/scd.2009.0212","volume":"19","author":"Y Lepelletier","year":"2010","unstructured":"Lepelletier Y et al (2010) Galectin-1 and semaphorin-3A are two soluble factors conferring T-cell immunosuppression to bone marrow mesenchymal stem cell. Stem Cells Dev 19:1075\u20131079. https:\/\/doi.org\/10.1089\/scd.2009.0212","journal-title":"Stem Cells Dev"},{"key":"3125_CR362","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.stemcr.2017.02.008","volume":"8","author":"N Espagnolle","year":"2017","unstructured":"Espagnolle N, Balguerie A, Arnaud E, Sensebe L, Varin A (2017) CD54-mediated interaction with pro-inflammatory macrophages increases the immunosuppressive function of human mesenchymal stromal cells. Stem Cell Reports 8:961\u2013976. https:\/\/doi.org\/10.1016\/j.stemcr.2017.02.008","journal-title":"Stem Cell Reports"},{"key":"3125_CR363","doi-asserted-by":"publisher","first-page":"e59354","DOI":"10.1371\/journal.pone.0059354","volume":"8","author":"ZX Yang","year":"2013","unstructured":"Yang ZX et al (2013) CD106 identifies a subpopulation of mesenchymal stem cells with unique immunomodulatory properties. PLoS One 8:e59354. https:\/\/doi.org\/10.1371\/journal.pone.0059354","journal-title":"PLoS One"},{"key":"3125_CR364","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/stem.2509","volume":"35","author":"LC Davies","year":"2017","unstructured":"Davies LC, Heldring N, Kadri N, Le Blanc K (2017) Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression. Stem Cells 35:766\u2013776. https:\/\/doi.org\/10.1002\/stem.2509","journal-title":"Stem Cells"},{"key":"3125_CR365","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/icb.2010.47","volume":"88","author":"S Tipnis","year":"2010","unstructured":"Tipnis S, Viswanathan C, Majumdar AS (2010) Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO. Immunol Cell Biol 88:795\u2013806. https:\/\/doi.org\/10.1038\/icb.2010.47","journal-title":"Immunol Cell Biol"},{"key":"3125_CR366","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/scd.2009.0076","volume":"19","author":"Q Xue","year":"2010","unstructured":"Xue Q et al (2010) The negative co-signaling molecule b7-h4 is expressed by human bone marrow-derived mesenchymal stem cells and mediates its T-cell modulatory activity. Stem Cells Dev 19:27\u201338. https:\/\/doi.org\/10.1089\/scd.2009.0076","journal-title":"Stem Cells Dev"},{"key":"3125_CR367","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.humimm.2012.12.011","volume":"74","author":"YZ Gu","year":"2013","unstructured":"Gu YZ et al (2013) Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells. Hum Immunol 74:267\u2013276. https:\/\/doi.org\/10.1016\/j.humimm.2012.12.011","journal-title":"Hum Immunol"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-019-03125-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-019-03125-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-019-03125-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T06:58:53Z","timestamp":1663397933000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-019-03125-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,4]]},"references-count":367,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["3125"],"URL":"https:\/\/doi.org\/10.1007\/s00018-019-03125-1","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,4]]},"assertion":[{"value":"3 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}